| Oregon Health Authority | 60.0 | 6 | 0 |
| Prelude Fertility | 60.0 | 3 | 1 |
| KINDERWUNSCHZENTRUM LOS ANGELES, INC. | 60.0 | 3 | 1 |
| Pacific Fertility Center Los Angeles (PFCLA) | 60.0 | 3 | 1 |
| Colorado Center for Reproductive Medicine | 51.1 | 2 | 1 |
| Mayo Clinic | 49.6 | 4 | 0 |
| Oregon Department of Consumer and Business Services | 49.6 | 4 | 0 |
| National Institute for Occupational Safety and Health | 42.7 | 3 | 0 |
| Vital and health statistics. Series 21, Data on natality, marriage, and divorce | 42.7 | 3 | 0 |
| Vital and health statistics. Series 5, Comparative international vital and health statistics reports | 42.7 | 3 | 0 |
| Pacific Fertility Center | 42.7 | 3 | 0 |
| Office of Readiness and Response | 42.7 | 3 | 0 |
| Challenges and strategies in building a foundational digital health data integration ecosystem: a systematic review and thematic synthesis | 42.7 | 3 | 0 |
| assisted reproductive technology | 40.0 | 0 | 4 |
| Impact of single embryo transfer policy on perinatal outcomes in fresh and frozen cycles—analysis of the Japanese Assisted Reproduction Technology registry between 2007 and 2012 | 40.0 | 0 | 4 |
| American Society for Reproductive Medicine | 38.6 | 1 | 1 |
| Reproductive Medicine Associates of New York | 38.6 | 1 | 1 |
| Reproductive Medicine Associates of New Jersey | 38.6 | 1 | 1 |
| fertility clinic | 34.5 | 0 | 3 |
| Fertility and Sterility | 34.5 | 0 | 3 |
| In vitromaturation of human oocytes: Its role in infertility treatment and new possibilities | 34.5 | 0 | 3 |
| <i>In vitro</i> fertilization in Japan — Early days of <i>in vitro</i> fertilization and embryo transfer and future prospects for assisted reproductive technology — | 34.5 | 0 | 3 |
| The role of assisted hatching in in vitro fertilization: a review of the literature. A committee opinion | 34.5 | 0 | 3 |
| Risk of breast cancer following fertility treatment—A registry based cohort study of parous women in Norway | 34.5 | 0 | 3 |
| A global perspective on assisted reproductive technology fertility treatment: an 8-country fertility specialist survey | 34.5 | 0 | 3 |
| Blastocyst culture and transfer in clinical-assisted reproduction | 34.5 | 0 | 3 |
| Limb-body wall complex in one fetus of a dizygotic twin pregnancy conceived by egg donation, in vitro fertilization and embryo transfer: prenatal diagnosis and literature review | 34.5 | 0 | 3 |
| The promise of in vitro maturation in assisted reproduction and fertility preservation. | 34.5 | 0 | 3 |
| Elective single-embryo transfer | 34.5 | 0 | 3 |
| In vitro maturation: a committee opinion | 34.5 | 0 | 3 |
| Blastocyst culture and transfer in clinical-assisted reproduction: a committee opinion | 34.5 | 0 | 3 |
| VACTERL association with hydrocephalus in a fetus conceived by in vitro fertilization and embryo transfer | 34.5 | 0 | 3 |
| Role of assisted hatching in in vitro fertilization: a guideline | 34.5 | 0 | 3 |
| Embryo transfer techniques: an American Society for Reproductive Medicine survey of current Society for Assisted Reproductive Technology practices | 34.5 | 0 | 3 |
| Assisted reproduction policies in Israel: a retrospective analysis of in vitro fertilization–embryo transfer | 34.5 | 0 | 3 |
| Physical health of singleton children born after frozen embryo transfer using slow freezing: a 3-year follow-up study | 34.5 | 0 | 3 |
| The relationship between the changes in the level of progesterone and the outcome ofin vitrofertilization-embryo transfer | 34.5 | 0 | 3 |
| Recommendations for development of an emergency plan for in vitro fertilization programs: a committee opinion | 34.5 | 0 | 3 |
| Guidelines for development of an emergency plan for in vitro fertilization programs | 34.5 | 0 | 3 |
| Egg donation in an in vitro fertilization program: an alternative approach to cycle synchronization and timing of embryo transfer | 34.5 | 0 | 3 |
| Embryo transfer by reproductive endocrinology fellows vs attending physicians: are live birth rates comparable? | 34.5 | 0 | 3 |
| Perspective on in vitro fertilization and embryo transfer. Stimulus for biomedical research in reproductive medicine | 34.5 | 0 | 3 |
| Efficacy and safety of frozen-thawed embryo transfer in women aged 35 to 42 years from the PURSUE randomized clinical trial | 34.5 | 0 | 3 |
| First pregnancy and live birth resulting from cryopreserved embryos obtained from in vitro matured oocytes after oophorectomy in an ovarian cancer patient | 34.5 | 0 | 3 |
| Congenital Malformations in Singleton Infants Conceived by Assisted Reproductive Technologies and Singleton Infants by Natural Conception in Tehran, Iran | 34.5 | 0 | 3 |
| A Focus on Maternal Health Before Assisted Reproduction: Results From a Pilot Survey of Canadian IVF Medical Directors | 34.5 | 0 | 3 |
| Pregnancy rates in donor oocyte cycles compared to similar autologous in vitro fertilization cycles: an analysis of 26,457 fresh cycles from the Society for Assisted Reproductive Technology | 34.5 | 0 | 3 |
| Guidelines for development of an emergency plan for in vitro fertilization programs | 34.5 | 0 | 3 |
| Parameters that influence the results of in vitro fertilization/embryo transfer: a study of an egg donation model | 34.5 | 0 | 3 |
| Infertility treatment strategy involving combined freeze-all embryos and single vitrified-warmed embryo transfer during hormonal replacement cycle for in vitro fertilization of women with hypogonadotropic hypogonadism | 34.5 | 0 | 3 |
| Single embryo implantation per IVF cycle: the answer to every request for assisted reproduction? | 34.5 | 0 | 3 |
| CLINICAL ASSISTED REPRODUCTION: Comparison of Recombinant and Urinary Follicle-Stimulating Hormone Preparations in Short-Term Gonadotropin Releasing Hormone Agonist Protocol for In Vitro Fertilization-Embryo Transfer | 34.5 | 0 | 3 |
| Beyond the American Society for Reproductive Medicine transfer guidelines: how many cleavage-stage embryos are safe to transfer in women ≥43 years old? | 34.5 | 0 | 3 |
| A Phase III Study of FE 999913 in Japanese Female Patients Undergoing Fertility Treatment | 34.5 | 0 | 3 |
| In vitro fertilization-embryo transfer (IVF-ET) in the United States: 1990 results from the IVF-ET Registry. Medical Research International. Society for Assisted Reproductive Technology (SART), The American Fertility Society | 34.5 | 0 | 3 |
| In vitro fertilization-embryo transfer (IVF-ET) in the United States: 1989 results from the IVF-ET Registry. Medical Research International, Society for Assisted Reproductive Technology, The American Fertility Society | 34.5 | 0 | 3 |
| In vitro fertilization-embryo transfer in the United States: 1988 results from the IVF-ET Registry. Medical Research International. Society for Assisted Reproductive Technology. American Fertility Society | 34.5 | 0 | 3 |
| Differential indications for surgical technics in reproductive medicine--microsurgery, in vitro fertilization and embryo transfer, gamete intrafallopian transfer and tubal embryo transfer | 34.5 | 0 | 3 |
| In vitro fertilization and other assisted reproduction. Vth World Congress on In Vitro Fertilization and Embryo Transfer. Norfolk, Virginia, April 5-10, 1987. Proceedings | 34.5 | 0 | 3 |
| The role of assisted hatching in in vitro fertilization: a review of the literature. A Committee opinion | 34.5 | 0 | 3 |
| Blastocyst culture and transfer in clinical-assisted reproduction | 34.5 | 0 | 3 |
| Assessment of United States fertility clinic websites according to the American Society for Reproductive Medicine (ASRM)/Society for Assisted Reproductive Technology (SART) guidelines | 34.5 | 0 | 3 |
| In vitro fertilization laboratory. Clinical features of assisted reproduction techniques. Male infertility treatment in a reproduction medicine centre | 34.5 | 0 | 3 |
| The role of assisted hatching in in vitro fertilization: a review of the literature. A Committee opinion | 34.5 | 0 | 3 |
| Acupuncture intervention combined with assisted reproductive technology: its different effects at different time points during the in vitro fertilization-embryo transfer course | 34.5 | 0 | 3 |
| Use of reproductive technology for sex selection for nonmedical reasons | 34.5 | 0 | 3 |
| Blastocyst culture and transfer in clinically assisted reproduction: a committee opinion | 34.5 | 0 | 3 |
| Elective Single Embryo Transfer in the Setting of Funded In Vitro Fertilization: Two Years' Experience in an Ontario Hospital-Based Fertility Clinic | 34.5 | 0 | 3 |
| Curative effect of assisted reproduction technology by Traditional Chinese Medicine multi-channel interventional therapy on 95 cases of in vitro fertilization and embryo transfer failure | 34.5 | 0 | 3 |
| Assessment of Turkey IVF (In Vitro Fertilization) websites according to the American Society for Reproductive Medicine (ASRM)/Society for Assisted Reproductive Technology (SART) guidelines | 34.5 | 0 | 3 |
| Virtual Reality Use in Assisted Reproductive Technology | 34.5 | 0 | 3 |
| How does freeze-all strategy compare with conventional in vitro fertilization and fresh embryo transfer during assisted reproduction? | 34.5 | 0 | 3 |
| GYN-FIV a.s. | 34.5 | 0 | 3 |
| Ferring Pharmaceuticals | 33.9 | 2 | 0 |
| Epi Info | 33.9 | 2 | 0 |
| Oregon Department of Transportation | 33.9 | 2 | 0 |
| Oregon Military Department | 33.9 | 2 | 0 |
| State Library of Oregon | 33.9 | 2 | 0 |
| Oregon State Police | 33.9 | 2 | 0 |
| Preventing Chronic Disease | 33.9 | 2 | 0 |
| Trustpilot | 33.9 | 2 | 0 |
| Allegheny Health Network | 33.9 | 2 | 0 |
| National Survey of Family Growth | 33.9 | 2 | 0 |
| National Vital Statistics System | 33.9 | 2 | 0 |
| NIOSH Power Tools Database | 33.9 | 2 | 0 |
| Oregon Higher Education Coordinating Commission | 33.9 | 2 | 0 |
| Oregon Chief Education Office | 33.9 | 2 | 0 |
| Morbidity and Mortality Weekly Report: Recommendations and Reports | 33.9 | 2 | 0 |
| Vital & health statistics. Series 3, Analytical and epidemiological studies | 33.9 | 2 | 0 |
| Vital and health statistics. Series 3, Analytical studies | 33.9 | 2 | 0 |
| Vital and health statistics. Ser. 4, Documents and committee reports | 33.9 | 2 | 0 |
| Vital and health statistics. Series 13, Data from the National Health Survey | 33.9 | 2 | 0 |
| Aging trends (Hyattsville, Md.) | 33.9 | 2 | 0 |
| NCHS data brief | 33.9 | 2 | 0 |
| MMWR supplements | 33.9 | 2 | 0 |
| National Center for Emerging and Zoonotic Infectious Diseases | 33.9 | 2 | 0 |
| Division of Parasitic Diseases and Malaria | 33.9 | 2 | 0 |
| San Diego Fertility Center | 33.9 | 2 | 0 |
| Chronic Disease Prevention and Health Promotion | 33.9 | 2 | 0 |
| Shady Grove Fertility Center | 33.9 | 2 | 0 |
| Robert Edwards | 27.3 | 0 | 2 |
| in vitro fertilization | 27.3 | 0 | 2 |
| egg donation | 27.3 | 0 | 2 |
| fertility tourism | 27.3 | 0 | 2 |
| Journal of Assisted Reproduction and Genetics | 27.3 | 0 | 2 |
| Reproductive Medicine and Biology | 27.3 | 0 | 2 |
| Ectopic pregnancy secondary to in vitro fertilisation-embryo transfer: pathogenic mechanisms and management strategies | 27.3 | 0 | 2 |
| Application of seminal plasma to female genital tract prior to embryo transfer in assisted reproductive technology cycles (IVF, ICSI and frozen embryo transfer) | 27.3 | 0 | 2 |
| Post-embryo transfer interventions for assisted reproduction technology cycles | 27.3 | 0 | 2 |
| In vitro maturation in subfertile women with polycystic ovarian syndrome undergoing assisted reproduction | 27.3 | 0 | 2 |
| Cleavage stage versus blastocyst stage embryo transfer in assisted reproductive technology | 27.3 | 0 | 2 |
| Human chorionic gonadotrophin priming for fertility treatment with in vitro maturation | 27.3 | 0 | 2 |
| Post-embryo transfer interventions for in vitro fertilization and intracytoplasmic sperm injection patients | 27.3 | 0 | 2 |
| In vitro maturation in subfertile women with polycystic ovarian syndrome undergoing assisted reproduction | 27.3 | 0 | 2 |
| Cleavage stage versus blastocyst stage embryo transfer in assisted reproductive technology | 27.3 | 0 | 2 |
| In vitro maturation in sub fertile patients with polycystic ovarian syndrome undergoing assisted reproduction | 27.3 | 0 | 2 |
| Soft versus firm embryo transfer catheters for assisted reproductive technology | 27.3 | 0 | 2 |
| Post embryo transfer interventions for in vitro fertilization / intracytoplasmic sperm injection patients | 27.3 | 0 | 2 |
| Day three versus day two embryo transfer following in vitro fertilization or intracytoplasmic sperm injection | 27.3 | 0 | 2 |
| Day 3 versus day 2 embryo transfer following in vitro fertilization or intracytoplasmic sperm injection | 27.3 | 0 | 2 |
| Current achievements and future research directions in ovarian tissue culture, in vitro follicle development and transplantation: implications for fertility preservation | 27.3 | 0 | 2 |
| First successful case of in vitro fertilization-embryo transfer with venom immunotherapy for hymenoptera sting allergy | 27.3 | 0 | 2 |
| Journal of Experimental & Clinical Assisted Reproduction: shaping the future of research and practice in reproductive endocrinology/infertility | 27.3 | 0 | 2 |
| Identification and isolation of embryonic stem cells in reproductive endocrinology: theoretical protocols for conservation of human embryos derived from in vitro fertilization | 27.3 | 0 | 2 |
| Cleavage stage versus blastocyst stage embryo transfer in assisted reproductive technology | 27.3 | 0 | 2 |
| Resurgence of Minimal Stimulation In Vitro Fertilization with A Protocol Consisting of Gonadotropin Releasing Hormone-Agonist Trigger and Vitrified-Thawed Embryo Transfer | 27.3 | 0 | 2 |
| Journal of in vitro fertilization and embryo transfer : IVF | 27.3 | 0 | 2 |
| Journal of fertilization. In vitro IVF worldwide reproductive medicine genetics & stem cell biology | 27.3 | 0 | 2 |
| Abdominal ectopic pregnancy after in vitro fertilization and single embryo transfer: a case report and systematic review | 27.3 | 0 | 2 |
| Debating Elective Single Embryo Transfer after in vitro Fertilization: A Plea for a Context-Sensitive Approach | 27.3 | 0 | 2 |
| Examining the evidence: progesterone supplementation during fresh and frozen embryo transfer | 27.3 | 0 | 2 |
| Hysteroscopic cervical canal shaving: a new therapy for cervical stenosis before embryo transfer in patients undergoing in vitro fertilization | 27.3 | 0 | 2 |
| Effects of co-administration of growth hormone(GH) and aspirin to women during in vitro fertilization and embryo transfer (IVF-ET) cycles | 27.3 | 0 | 2 |
| Delivery rate using cryopreserved oocytes is comparable to conventional in vitro fertilization using fresh oocytes: potential fertility preservation for female cancer patients | 27.3 | 0 | 2 |
| Similarin vitromaturation rates of oocytes retrieved during the follicular or luteal phase offer flexible options for urgent fertility preservation in breast cancer patients | 27.3 | 0 | 2 |
| Serum progestagen-associated endometrial protein (PEP) levels in conception versus nonconception cycles following in vitro fertilization-embryo transfer | 27.3 | 0 | 2 |
| Urinary bisphenol A concentrations and association within vitrofertilization outcomes among women from a fertility clinic | 27.3 | 0 | 2 |
| Impact of men's dairy intake on assisted reproductive technology outcomes among couples attending a fertility clinic | 27.3 | 0 | 2 |
| Urinary paraben concentrations and in vitro fertilization outcomes among women from a fertility clinic | 27.3 | 0 | 2 |
| Dietary folate intake and modification of the association of urinary bisphenol A concentrations with in vitro fertilization outcomes among women from a fertility clinic | 27.3 | 0 | 2 |
| Hair mercury concentrations and in vitro fertilization (IVF) outcomes among women from a fertility clinic | 27.3 | 0 | 2 |
| Maternal whole grain intake and outcomes of in vitro fertilization | 27.3 | 0 | 2 |
| Day three versus day two embryo transfer following in vitro fertilization or intracytoplasmic sperm injection. | 27.3 | 0 | 2 |
| Human chorionic gonadotrophin priming for fertility treatment with in vitro maturation. | 27.3 | 0 | 2 |
| Predictors of participant retention in infertility treatment trials | 27.3 | 0 | 2 |
| Randomized Trial of Harp Therapy During In Vitro Fertilization–Embryo Transfer | 27.3 | 0 | 2 |
| First-trimester diagnosis and management of Cesarean scar pregnancies after in vitro fertilization-embryo transfer: a retrospective clinical analysis of 12 cases | 27.3 | 0 | 2 |
| Immunoregulation of follicular renewal, selection, POF, and menopause in vivo, vs. neo-oogenesis in vitro, POF and ovarian infertility treatment, and a clinical trial | 27.3 | 0 | 2 |
| In vitro fertilization - analysis of data in Czech National Assisted Reproduction Register from years 2007-2011 | 27.3 | 0 | 2 |
| Obligatory versus elective single embryo transfer in in vitro fertilization. A population-based analysis of data from the U.K. Human Fertilisation and Embryology Authority | 27.3 | 0 | 2 |
| Risk of major congenital anomalies after assisted hatching: analysis of three-year data from the national assisted reproduction registry in Japan | 27.3 | 0 | 2 |
| Laparoscopic management of hydrosalpinges before in vitro fertilization-embryo transfer: salpingectomy versus proximal tubal occlusion | 27.3 | 0 | 2 |
| Outcomes of in vitro fertilization with preimplantation genetic diagnosis: an analysis of the United States Assisted Reproductive Technology Surveillance Data, 2011-2012 | 27.3 | 0 | 2 |
| Effectiveness of in vitro fertilization with preimplantation genetic screening: a reanalysis of United States assisted reproductive technology data 2011–2012 | 27.3 | 0 | 2 |
| Could induced apoptosis of human granulosa cells predict in vitro fertilization-embryo transfer outcome? A preliminary study of 25 women. | 27.3 | 0 | 2 |
| Impact of intramural leiomyomata in patients with a normal endometrial cavity on in vitro fertilization-embryo transfer cycle outcome | 27.3 | 0 | 2 |
| Risk assessment of mouse hepatitis virus infection via in vitro fertilization and embryo transfer by the use of zona-intact and laser-microdissected oocytes | 27.3 | 0 | 2 |
| Pregnancy outcomes after assisted reproductive technology | 27.3 | 0 | 2 |
| Laser assisted hatching in good prognosis patients undergoing in vitro fertilization-embryo transfer: a randomized controlled trial | 27.3 | 0 | 2 |
| Human spermatozoa ultrastructure assessment in the infertility treatment by assisted reproduction technique | 27.3 | 0 | 2 |
| Fertility clinic, egg donation agency, and sperm bank policies | 27.3 | 0 | 2 |
| Primate Follicular Development and Oocyte Maturation In Vitro | 27.3 | 0 | 2 |
| Increasing and decreasing factors of hope in infertile women with failure in infertility treatment: A phenomenology study | 27.3 | 0 | 2 |
| Intrauterine administration of recombinant human chorionic gonadotropin before embryo transfer on outcome of in vitro fertilization/ intracytoplasmic sperm injection: A randomized clinical trial | 27.3 | 0 | 2 |
| The status of assisted reproductive technology in Korea in 2012 | 27.3 | 0 | 2 |
| The impact of atosiban on pregnancy outcomes in women undergoing in vitro fertilization-embryo transfer: A meta-analysis | 27.3 | 0 | 2 |
| Elective single embryo transfer following in vitro fertilization | 27.3 | 0 | 2 |
| Fertility Preservation in Cancer Patients: In Vivo and In Vitro Options | 27.3 | 0 | 2 |
| Assisted reproduction-in vitro fertilization success is improved by ovarian stimulation with exogenous gonadotropins and pituitary suppression with gonadotropin-releasing hormone analogues | 27.3 | 0 | 2 |
| Impacts of Anti-dsDNA Antibody on In Vitro Fertilization-Embryo Transfer and Frozen-Thawed Embryo Transfer. | 27.3 | 0 | 2 |
| The efficacy and adverse effects of in vitro fertilization and embryo transfer | 27.3 | 0 | 2 |
| GnRH antagonist for patients with polycystic ovary syndrome undergoing controlled ovarian hyperstimulation for in vitro fertilization and embryo transfer in fresh cycles | 27.3 | 0 | 2 |
| Serum Progesterone Elevation Adversely Affects Cumulative Live Birth Rate in Different Ovarian Responders during In Vitro Fertilization and Embryo Transfer: A Large Retrospective Study | 27.3 | 0 | 2 |
| Combined analysis of endometrial thickness and pattern in predicting outcome of in vitro fertilization and embryo transfer: a retrospective cohort study | 27.3 | 0 | 2 |
| The incidence of monozygotic twinning in assisted reproductive technology: Analysis based on results from the 2010 Japanese ART national registry | 27.3 | 0 | 2 |
| The Photosensitivity Localized in a Vitiliginous Lesion Was Associated with the Intramuscular Injections of Synthetic Progesterone during an In Vitro Fertilization-embryo Transfer | 27.3 | 0 | 2 |
| Minimal precycle testing and ongoing cycle monitoring for in vitro fertilization and fresh pre-embryo transfer do not compromise fertilization, implantation, or ongoing pregnancy rates | 27.3 | 0 | 2 |
| Comparison of clinical outcomes between fresh embryo transfers and frozen-thawed embryo transfers | 27.3 | 0 | 2 |
| Does prayer influence the success of in vitro fertilization-embryo transfer? Report of a masked, randomized trial. | 27.3 | 0 | 2 |
| In vitro manipulation of nonhuman primate gametes for embryo production and embryo transfer | 27.3 | 0 | 2 |
| Phytoestrogens may improve the pregnancy rate in in vitro fertilization-embryo transfer cycles: a prospective, controlled, randomized trial | 27.3 | 0 | 2 |
| Evaluation of clinical factors influencing pregnancy rate in frozen embryo transfer | 27.3 | 0 | 2 |
| The importance of the cleavage stage morphology evaluation for blastocyst transfer in patients with good prognosis | 27.3 | 0 | 2 |
| Effect of male hepatitis B virus infection on outcomes of in vitro fertilization and embryo transfer treatment: insights from couples undergoing oocyte donation | 27.3 | 0 | 2 |
| Predictive value of plasma human chorionic gonadotrophin beta subunit in diagnosing ectopic pregnancy after in vitro fertilisation and embryo transfer | 27.3 | 0 | 2 |
| Impact of short-term preconceptional exposure to particulate air pollution on treatment outcome in couples undergoing in vitro fertilization and embryo transfer (IVF/ET) | 27.3 | 0 | 2 |
| How the FMR1 gene became relevant to female fertility and reproductive medicine | 27.3 | 0 | 2 |
| Fertility preservation outcomes may differ by cancer diagnosis | 27.3 | 0 | 2 |
| Term delivery following pyometra after in vitro fertilization and embryo transfer | 27.3 | 0 | 2 |
| In vitro technologies related to pig embryo transfer. | 27.3 | 0 | 2 |
| Eight-hydroxy-2'-deoxyguanosine in granulosa cells is correlated with the quality of oocytes and embryos in an in vitro fertilization-embryo transfer program | 27.3 | 0 | 2 |
| The outcome of infertility treatment in patients undergoing assisted reproductive technology after conservative therapy for endometrial cancer | 27.3 | 0 | 2 |
| The breadth of in vitro fertilization and embryo transfer | 27.3 | 0 | 2 |
| Delivery after intrauterine embryo transfer obtained by fertilization and oocyte culture in vitro | 27.3 | 0 | 2 |
| Efficacy of the local endometrial injury in patients who had previous failed IVF-ICSI outcome | 27.3 | 0 | 2 |
| Cornual heterotopic pregnancy and cornual resection after in vitro fertilization/embryo transfer. A report of two cases | 27.3 | 0 | 2 |
| Parameters that predict success for natural cycle in vitro fertilization-embryo transfer | 27.3 | 0 | 2 |
| Is tubal embryo transfer of any value? A meta-analysis and comparison with the Society for Assisted Reproductive Technology database | 27.3 | 0 | 2 |
| Endometrial thickness affects the outcome of in vitro fertilization and embryo transfer in normal responders after GnRH antagonist administration | 27.3 | 0 | 2 |
| Use of third generation gonadotropin-releasing hormone antagonists in in vitro fertilization-embryo transfer: a review | 27.3 | 0 | 2 |
| Efficacy and safety of long-acting GnRH agonists in in vitro fertilization and embryo transfer. | 27.3 | 0 | 2 |
| Gene expression and DNA-methylation of bovine pretransfer endometrium depending on its receptivity after in vitro-produced embryo transfer | 27.3 | 0 | 2 |
| Fresh embryo transfer versus frozen embryo transfer in in vitro fertilization cycles: a systematic review and meta-analysis | 27.3 | 0 | 2 |
| Factors influencing pregnancy rates with a combined clomiphene citrate/gonadotropin protocol for non-assisted reproductive technology fertility treatment | 27.3 | 0 | 2 |
| Marked improvement in clinical pregnancy rates following in vitro fertilization-embryo transfer seen when transfer technique and catheter were changed. | 27.3 | 0 | 2 |
| Live birth sex ratio after in vitro fertilization and embryo transfer in China--an analysis of 121,247 babies from 18 centers | 27.3 | 0 | 2 |
| Effect of glucose concentration during in vitro culture of mouse embryos on development to blastocyst, success of embryo transfer, and litter sex ratio | 27.3 | 0 | 2 |
| Assisted reproduction and reproductive rights: the case of in vitro fertilization | 27.3 | 0 | 2 |
| Reproductive medicine 2014: the year in review | 27.3 | 0 | 2 |
| Does IVF cleavage stage embryo quality affect pregnancy complications and neonatal outcomes in singleton gestations after double embryo transfers? | 27.3 | 0 | 2 |
| Concurrent ovarian and ipsilateral tubal ectopic pregnancies after a double embryo transfer: a case report | 27.3 | 0 | 2 |
| In vitro fertilisation and embryo transfer for bilateral salpingectomies results in a ruptured ovarian ectopic pregnancy due to a tubal stump fistula: a case report and review of the literature | 27.3 | 0 | 2 |
| Interstitial pregnancy after in vitro fertilization and embryo transfer following bilateral salpingectomy: report of two cases and literature review | 27.3 | 0 | 2 |
| Access to fertility treatment by gays, lesbians, and unmarried persons: a committee opinion | 27.3 | 0 | 2 |
| Do polymorphic variants of chromosomes affect the outcome of in vitro fertilization and embryo transfer treatment? | 27.3 | 0 | 2 |
| Treatment-independent pregnancy after in vitro fertilization and embryo transfer trial | 27.3 | 0 | 2 |
| The Effect of Single Embryo Transfer on Perinatal Outcomes in Japan | 27.3 | 0 | 2 |
| Uncomplicated pregnancy and normal singleton delivery after surgical excision of heterotopic (cornual) pregnancy following in vitro fertilization/embryo transfer | 27.3 | 0 | 2 |
| Prevention of multiple pregnancies in couples with unexplained or mild male subfertility: randomised controlled trial of in vitro fertilisation with single embryo transfer or in vitro fertilisation in modified natural cycle compared with intrauterin | 27.3 | 0 | 2 |
| Morphokinetic analysis of cleavage stage embryos and its relationship to aneuploidy in a retrospective time-lapse imaging study | 27.3 | 0 | 2 |
| The clinical outcomes of day 3 4-cell embryos after extended in vitro culture | 27.3 | 0 | 2 |
| A healthy delivery of twins by assisted reproduction followed by preimplantation genetic screening in a woman with X-linked dominant incontinentia pigmenti | 27.3 | 0 | 2 |
| Two interesting cases of ovarian pregnancy after in vitro fertilization-embryo transfer and its successful laparoscopic management | 27.3 | 0 | 2 |
| Duration of progesterone-in-oil support after in vitro fertilization and embryo transfer: a randomized, controlled trial | 27.3 | 0 | 2 |
| Fertility treatment when the prognosis is very poor or futile | 27.3 | 0 | 2 |
| Access to fertility treatment by gays, lesbians, and unmarried persons | 27.3 | 0 | 2 |
| In vitro production of bovine embryos and their application for embryo transfer | 27.3 | 0 | 2 |
| Live birth after in vitro fertilization and single embryo transfer in a kidney transplant patient: a case report and review of the literature | 27.3 | 0 | 2 |
| Thirteen -weeks ovarian pregnancy following in vitro fertilization for primary infertility treatment: A case report | 27.3 | 0 | 2 |
| Effects of Liuwei Dihuang Granule ([symbols; see text]) on the outcomes of in vitro fertilization pre-embryo transfer in infertility women with Kidney-yin deficiency syndrome and the proteome expressions in the follicular fluid. | 27.3 | 0 | 2 |
| Effect of single embryo transfer on the risk of preterm birth associated with in vitro fertilization | 27.3 | 0 | 2 |
| Hospital mental health admissions in women after unsuccessful infertility treatment and in vitro fertilization: an Australian population-based cohort study | 27.3 | 0 | 2 |
| Children conceived by in vitro fertilisation after fresh embryo transfer | 27.3 | 0 | 2 |
| Normal epigenetic inheritance in mice conceived by in vitro fertilization and embryo transfer | 27.3 | 0 | 2 |
| Comparison of the effect of different media on the clinical outcomes of the density-gradient centrifugation/swim-up and swim-up methods | 27.3 | 0 | 2 |
| Successful Delivery Following Staphylococcus aureus Bacteremia after In Vitro Fertilization and Embryo Transfer | 27.3 | 0 | 2 |
| A Case of Pregnancy Complicated by the Development of a Tubo-ovarian Abscess Following In Vitro Fertilization and Embryo Transfer | 27.3 | 0 | 2 |
| Does surgical management of endometriosis within 6 months of an in vitro fertilization-embryo transfer cycle improve outcome? | 27.3 | 0 | 2 |
| Application of a validated prediction model for in vitro fertilization: comparison of live birth rates and multiple birth rates with 1 embryo transferred over 2 cycles vs 2 embryos in 1 cycle | 27.3 | 0 | 2 |
| Canadian medical tourism companies that have exited the marketplace: Content analysis of websites used to market transnational medical travel. | 27.3 | 0 | 2 |
| In vitro fertilization and embryo transfer outcomes in relation to myometrial thickness. | 27.3 | 0 | 2 |
| Heart Failure Remote Monitoring: Evidence From the Retrospective Evaluation of a Real-World Remote Monitoring Program | 27.3 | 0 | 2 |
| Laparoscopic excision of ovarian endometrioma does not exert a qualitative effect on ovarian function: insights from in vitro fertilization and single embryo transfer cycles | 27.3 | 0 | 2 |
| Noninvasive Digital Detection of Fetal DNA in Plasma of 4-Week-Pregnant Women following In Vitro Fertilization and Embryo Transfer | 27.3 | 0 | 2 |
| Effect of infertility treatment and pregnancy-related hormones on breast cell proliferation in vitro | 27.3 | 0 | 2 |
| Combined strategy for fertility preservation in an oncologic patient: vitrification of in vitro matured oocytes and ovarian tissue freezing | 27.3 | 0 | 2 |
| The Management of Uterine Fibroids in Women With Otherwise Unexplained Infertility | 27.3 | 0 | 2 |
| Clinical analysis of spontaneous pregnancy reduction in the patients with multiple pregnancies undergoing in vitro fertilization/intracytoplasmic sperm injection-embryo transfer | 27.3 | 0 | 2 |
| Relationship between Antithyroid Antibody and Pregnancy Outcome following in Vitro Fertilization and Embryo Transfer | 27.3 | 0 | 2 |
| Optimal timing for elective egg freezing | 27.3 | 0 | 2 |
| Serum estradiol/progesterone ratio on day of embryo transfer may predict reproductive outcome following controlled ovarian hyperstimulation and in vitro fertilization | 27.3 | 0 | 2 |
| What is the most relevant standard of success in assisted reproduction?: challenges in measuring and reporting success rates for assisted reproductive technology treatments: what is optimal? | 27.3 | 0 | 2 |
| The dynamics of the vaginal microbiome during infertility therapy with in vitro fertilization-embryo transfer. | 27.3 | 0 | 2 |
| Does obesity have detrimental effects on IVF treatment outcomes? | 27.3 | 0 | 2 |
| Predictive value of age-specific FSH levels for IVF-ET outcome in women with normal ovarian function | 27.3 | 0 | 2 |
| Human iPS Cell-Derived Germ Cells: Current Status and Clinical Potential | 27.3 | 0 | 2 |
| In vitro fertilization in humans and embryo transfer | 27.3 | 0 | 2 |
| Miliary tuberculosis after in vitro fertilization and embryo transplantation | 27.3 | 0 | 2 |
| Patients with polycystic ovary syndrome have successful embryo arrest | 27.3 | 0 | 2 |
| What is the most relevant standard of success in assisted reproduction? Redefining success in the context of elective single embryo transfer: evidence, intuition and financial reality | 27.3 | 0 | 2 |
| Population pharmacokinetic modelling of Emfilermin (recombinant human leukaemia inhibitory factor, r-hLIF) in healthy postmenopausal women and in infertile patients undergoing in vitro fertilization and embryo transfer | 27.3 | 0 | 2 |
| Uterine abscess after ultrasound-guided ovum retrieval in an in vitro fertilization-embryo transfer program: case report and review of the literature | 27.3 | 0 | 2 |
| Single or multiple embryo transfer following in vitro fertilisation for improved neonatal outcome: a systematic review of the literature | 27.3 | 0 | 2 |
| Heterotopic pregnancy after in vitro fertilization-embryo transfer | 27.3 | 0 | 2 |
| Salpingectomy for hydrosalpinx prior to in vitro fertilization | 27.3 | 0 | 2 |
| The role of assisted hatching in in vitro fertilization: A review of the literature | 27.3 | 0 | 2 |
| Clinical application of sperm-oocyte interaction tests in in vitro fertilization--embryo transfer and intracytoplasmic sperm injection programs | 27.3 | 0 | 2 |
| Methotrexate does not affect ovarian reserve or subsequent assisted reproductive technology outcomes | 27.3 | 0 | 2 |
| Correlation of serum Anti-Müllerian hormone concentrations on day 3 of the in vitro fertilization stimulation cycle with assisted reproduction outcome in polycystic ovary syndrome patients | 27.3 | 0 | 2 |
| The best infertility treatment for vasectomized men: assisted reproduction or vasectomy reversal? | 27.3 | 0 | 2 |
| Increased risk of preterm birth in singleton pregnancies resulting from in vitro fertilization-embryo transfer or gamete intrafallopian transfer: a meta-analysis | 27.3 | 0 | 2 |
| The Maternal Cytokine and Chemokine Profile of Naturally Conceived Gestations Is Mainly Preserved duringIn VitroFertilization and Egg Donation Pregnancies | 27.3 | 0 | 2 |
| Impact of estrogen-to-oocyte ratio on live birth rate in women undergoing in vitro fertilization and embryo transfer | 27.3 | 0 | 2 |
| Therapeutic maturation of endometrium in in vitro fertilization and embryo transfer | 27.3 | 0 | 2 |
| Regional clinical practice patterns in reproductive endocrinology: a collaborative transnational pilot survey of in vitro fertilization programs in the Middle East | 27.3 | 0 | 2 |
| In vivo and in vitro decondensation of human sperm and assisted reproduction technologies | 27.3 | 0 | 2 |
| The association of serum estradiol level with outcomes of clomiphene citrate/human menopausal gonadotropin ovarian stimulation for in vitro fertilization and embryo transfer | 27.3 | 0 | 2 |
| Embryo transfer practices and multiple births resulting from assisted reproductive technology: an opportunity for prevention | 27.3 | 0 | 2 |
| Three pro-nuclei (3PN) incidence factors and clinical outcomes: a retrospective study from the fresh embryo transfer of in vitro fertilization with donor sperm (IVF-D) | 27.3 | 0 | 2 |
| New strategy for in vitro activation of primordial follicles with mTOR and PI3K stimulators | 27.3 | 0 | 2 |
| Embryo transfer following in vitro maturation and cryopreservation of oocytes recovered from antral follicles during conservative surgery for ovarian cancer | 27.3 | 0 | 2 |
| Soft versus firm embryo transfer catheters for assisted reproduction: a systematic review and meta-analysis | 27.3 | 0 | 2 |
| Comparison of genome-wide and gene-specific DNA methylation between ART and naturally conceived pregnancies | 27.3 | 0 | 2 |
| GnRH agonist versus GnRH antagonist in in vitro fertilization and embryo transfer (IVF/ET). | 27.3 | 0 | 2 |
| Efficacy of oxytocin antagonist infusion in improving in vitro fertilization outcomes on the day of embryo transfer: A meta-analysis | 27.3 | 0 | 2 |
| Egg donation brokers: an analysis of agency versus in vitro fertilization clinic websites | 27.3 | 0 | 2 |
| The current status of sperm donation in assisted reproduction technology: ethical and legal considerations | 27.3 | 0 | 2 |
| Birth of rhesus monkey infant after in vitro fertilization and nonsurgical embryo transfer | 27.3 | 0 | 2 |
| A case of primary ovarian pregnancy after in vitro fertilization and embryo transfer | 27.3 | 0 | 2 |
| A successful pregnancy with in vitro fertilization and embryo transfer in an infertile woman with Kartagener's syndrome: a case report | 27.3 | 0 | 2 |
| Contamination of embryo transfer catheter and treatment outcome in in vitro fertilization | 27.3 | 0 | 2 |
| Differences in female and male perception of information and decision-making in single-embryo transfer in in vitro fertilization in Sweden | 27.3 | 0 | 2 |
| Autologous endometrial co-culture in patients with repeated failures of implantation after in vitro fertilization-embryo transfer | 27.3 | 0 | 2 |
| The reproductive performance of women with hypogonadotropic hypogonadism in an in vitro fertilization and embryo transfer program | 27.3 | 0 | 2 |
| Involvement of interleukin-1 and the interleukin-1 receptor antagonist in in vitro embryo development among women undergoing in vitro fertilization-embryo transfer | 27.3 | 0 | 2 |
| Early hormonal markers of pregnancy outcome after in vitro fertilization and embryo transfer | 27.3 | 0 | 2 |
| Abdominal ultrasound-guided embryo transfer improves clinical pregnancy rates after in vitro fertilization: experiences from 330 clinical investigations | 27.3 | 0 | 2 |
| Number and size of antral follicles as predictive factors in vitro fertilization and embryo transfer | 27.3 | 0 | 2 |
| Is intravenous immunoglobulins (IVIG) efficacious in early pregnancy failure? A critical review and meta-analysis for patients who fail in vitro fertilization and embryo transfer (IVF). | 27.3 | 0 | 2 |
| Controlled ovarian hyperstimulation adversely affects implantation following in vitro fertilization-embryo transfer | 27.3 | 0 | 2 |
| Defining women who are prone to have twins in in vitro fertilization--a necessary step towards single embryo transfer | 27.3 | 0 | 2 |
| Bilateral ovarian pregnancy after in vitro fertilization and embryo transfer in a patient with tubal factor infertility | 27.3 | 0 | 2 |
| The effect of smoking on oocyte quality and hormonal parameters of patients undergoing in vitro fertilization-embryo transfer | 27.3 | 0 | 2 |
| Prediction of pregnancy rate of in vitro fertilization and embryo transfer in women aged 40 and over with basal uterine artery pulsatility index | 27.3 | 0 | 2 |
| Subpopulations of human granulosa-luteal cells obtained from gonadotropin- or gonadotropin-releasing hormone agonist/gonadotropin-treated follicles in in vitro fertilization-embryo transfer cycles | 27.3 | 0 | 2 |
| Seasonal influences on in vitro fertilization and embryo transfer | 27.3 | 0 | 2 |
| Serum progesterone before and after human chorionic gonadotropin injection depends on the estradiol response to ovarian hyperstimulation during in vitro fertilization-embryo transfer cycles | 27.3 | 0 | 2 |
| Is intracytoplasmic sperm injection necessary for couples undergoing in vitro fertilization-embryo transfer with normal semen analyses but failing hamster egg penetration assays? | 27.3 | 0 | 2 |
| Day 6 estradiol level predicts cycle cancellation among poor responder patients undergoing in vitro fertilization-embryo transfer cycles using a gonadotropin-releasing hormone agonist flare regimen | 27.3 | 0 | 2 |
| Effect of a sonographically diffusely enlarged uterus without distinct uterine masses on the outcome of in vitro fertilization-embryo transfer | 27.3 | 0 | 2 |
| Correlation of NK cell activation and inhibition markers with NK cytoxicity among women experiencing immunologic implantation failure after in vitro fertilization and embryo transfer | 27.3 | 0 | 2 |
| Hypothalamic-pituitary suppression with oral contraceptive pills does not improve outcome in poor responder patients undergoing in vitro fertilization-embryo transfer cycles | 27.3 | 0 | 2 |
| Combined intrauterine, tubal, and cervical pregnancies following in vitro fertilization and embryo transfer | 27.3 | 0 | 2 |
| Birth of a healthy infant after in vitro fertilization and embryo transfer in patient of total uterine prolapse | 27.3 | 0 | 2 |
| Review of scientific contributions by the Belgian medical centers concerned with human in vitro fertilization and embryo transfer (IVF) | 27.3 | 0 | 2 |
| Impact of varying stages of endometriosis on the outcome of in vitro fertilization-embryo transfer | 27.3 | 0 | 2 |
| Clinical significance of transvaginal color Doppler ultrasonography of the ovarian artery as a predictor of ovarian response in controlled ovarian hyperstimulation for in vitro fertilization and embryo transfer | 27.3 | 0 | 2 |
| Recruiting egg donors online: an analysis of in vitro fertilization clinic and agency websites' adherence to American Society for Reproductive Medicine guidelines | 27.3 | 0 | 2 |
| Overt leptin response to controlled ovarian hyperstimulation negatively correlates with pregnancy outcome in in vitro fertilization--embryo transfer cycle | 27.3 | 0 | 2 |
| Firm embryo transfer catheters for assisted reproduction: a systematic review and meta-analysis using direct and adjusted indirect comparisons | 27.3 | 0 | 2 |
| Associations between paternal urinary phthalate metabolite concentrations and reproductive outcomes among couples seeking fertility treatment | 27.3 | 0 | 2 |
| Beyond "medical tourism": Canadian companies marketing medical travel. | 27.3 | 0 | 2 |
| Oncofertility: a grand collaboration between reproductive medicine and oncology | 27.3 | 0 | 2 |
| Embryo transfer in days 2 to 4 following intracytoplasmic sperm injection: a prospective cohort study | 27.3 | 0 | 2 |
| Clustering of monozygotic twinning in IVF | 27.3 | 0 | 2 |
| Anti-Müllerian hormone levels as a predictor of clinical pregnancy inin vitrofertilization/intracytoplasmic sperm injection-embryo transfer cycles in patients over 40 years of age | 27.3 | 0 | 2 |
| Altered Preconception Fatty Acid Intake Is Associated with Improved Pregnancy Rates in Overweight and Obese Women Undertaking in Vitro Fertilisation | 27.3 | 0 | 2 |
| Second-trimester heterotopic pregnancy after in vitro fertilization and embryo transfer--a case report and review of the literature. | 27.3 | 0 | 2 |
| Comparison of assisted reproductive technology outcomes in infertile women with polycystic ovary syndrome:In vitromaturation, GnRH agonist, and GnRH antagonist cycles | 27.3 | 0 | 2 |
| Human in vitro fertilization and embryo transfer | 27.3 | 0 | 2 |
| Effect of Cancer on Ovarian Function in Patients Undergoing In Vitro Fertilization for Fertility Preservation: A Reappraisal | 27.3 | 0 | 2 |
| Dairy intake in relation to in vitro fertilization outcomes among women from a fertility clinic. | 27.3 | 0 | 2 |
| Evidence that exposure to progesterone alone is a sufficient stimulus to cause a precipitous rise in the immunomodulatory protein the progesterone induced blocking factor (PIBF) | 27.3 | 0 | 2 |
| In vitro maturation of human oocytes for assisted reproduction | 27.3 | 0 | 2 |
| Preliminary data on our experience of in vitro fertilization-embryo transfer in the treatment of sterility | 27.3 | 0 | 2 |
| Genetic considerations related to intracytoplasmic sperm injection (ICSI). | 27.3 | 0 | 2 |
| Guidelines for reducing the risk of viral transmission during fertility treatment | 27.3 | 0 | 2 |
| Round spermatid nucleus injection (ROSNI). | 27.3 | 0 | 2 |
| Effects of culture media conditions on production of eggs fertilized in vitro of embryos derived from ovary of high grade Hanwoo | 27.3 | 0 | 2 |
| Single thawed euploid embryo transfer improves IVF pregnancy, miscarriage, and multiple gestation outcomes and has similar implantation rates as egg donation. | 27.3 | 0 | 2 |
| A logistic model to predict early pregnancy loss following in vitro fertilization based on 2601 infertility patients | 27.3 | 0 | 2 |
| Comparing blastocyst quality and live birth rates of intravaginal culture using INVOcell™ to traditional in vitro incubation in a randomized open-label prospective controlled trial | 27.3 | 0 | 2 |
| The impact of patient preselection on reported IVF outcomes | 27.3 | 0 | 2 |
| Early Lessons Learned in Implementing a Women’s Health Educational and Virtual Consultation Program in VA | 27.3 | 0 | 2 |
| Current status of assisted reproductive technology in Korea, 2011 | 27.3 | 0 | 2 |
| A case of Baller-Gerold syndrome following in vitro fertilization-embryo transfer | 27.3 | 0 | 2 |
| Economic Evaluation of In Vitro Fertilization with Embryo Transfer and Neosalpingostomy by Laparotomy or Laparoscopy | 27.3 | 0 | 2 |
| Serum anti-Müllerian hormone and inhibin B levels at ovulation triggering day can predict the number of immature oocytes retrieved in in vitro fertilization cycles | 27.3 | 0 | 2 |
| Comparison of clinical efficacy between a single administration of long-acting gonadotrophin-releasing hormone agonist (GnRHa) and daily administrations of short-acting GnRHa in in vitro fertilization-embryo transfer cycles | 27.3 | 0 | 2 |
| The predictive value of anti-Mullerian hormone on embryo quality, blastocyst development, and pregnancy rate following in vitro fertilization-embryo transfer (IVF-ET). | 27.3 | 0 | 2 |
| Does a strategy to promote shared decision-making reduce medical practice variation in the choice of either single or double embryo transfer after in vitro fertilisation? A secondary analysis of a randomised controlled trial | 27.3 | 0 | 2 |
| The correlation between endometrial thickness and outcome of in vitro fertilization and embryo transfer (IVF-ET) outcome | 27.3 | 0 | 2 |
| Outcomes of intracytoplasmic sperm injection using the zona pellucida-bound sperm or manually selected sperm | 27.3 | 0 | 2 |
| Time-lapse variables and embryo gender: a retrospective analysis of 81 live births obtained following minimal stimulation and single embryo transfer | 27.3 | 0 | 2 |
| In vitro spermatogenesis as a method to bypass pre-meiotic or post-meiotic barriers blocking the spermatogenetic process: genetic and epigenetic implications in assisted reproductive technology | 27.3 | 0 | 2 |
| A Case of Secondary Abdominal Pregnancy after in Vitro Fertilization Pre-Embryo Transfer (IVF-ET). | 27.3 | 0 | 2 |
| Cryopreservation/transplantation of ovarian tissue and in vitro maturation of follicles and oocytes: challenges for fertility preservation | 27.3 | 0 | 2 |
| Use of letrozole in assisted reproduction: a systematic review and meta-analysis. | 27.3 | 0 | 2 |
| Vitrification of in vitro matured oocytes collected from surplus ovarian medulla tissue resulting from fertility preservation of ovarian cortex tissue | 27.3 | 0 | 2 |
| Association of progesterone receptor polymorphisms with recurrent implantation failure after in vitro fertilization and embryo transfer | 27.3 | 0 | 2 |
| Hyaluronan in follicular fluid and embryo implantation following in vitro fertilization and embryo transfer | 27.3 | 0 | 2 |
| Preimplantation genetic testing: a Practice Committee opinion | 27.3 | 0 | 2 |
| In vitro fertilization and embryo transfer: a brief overview | 27.3 | 0 | 2 |
| Elevated day 3 follicle-stimulating hormone/luteinizing hormone ratio >or= 2 is associated with higher rates of cancellation in in vitro fertilization-embryo transfer cycles. | 27.3 | 0 | 2 |
| Impact of different embryo loading techniques on pregnancy rates in in vitro fertlization/embryo transfer cycles | 27.3 | 0 | 2 |
| The effectiveness of earlier oocyte retrieval in the case of a premature luteinizing hormone surge on hCG day in in vitro fertilization-embryo transfer cycles | 27.3 | 0 | 2 |
| Effects of polycystic ovarian syndrome on in vitro fertilization-embryo transfer outcomes are influenced by body mass index | 27.3 | 0 | 2 |
| The total pregnancy potential per oocyte aspiration after assisted reproduction—in how many cycles are biologically competent oocytes available? | 27.3 | 0 | 2 |
| Safety of assisted reproduction, assessed by risk of abnormalities in children born after use of in vitro fertilization techniques | 27.3 | 0 | 2 |
| Previous tubal ectopic pregnancy raises the incidence of repeated ectopic pregnancies in in vitro fertilization-embryo transfer patients | 27.3 | 0 | 2 |
| Complications in pregnancies after in vitro fertilization and embryo transfer | 27.3 | 0 | 2 |
| Pregnancy, Delivery, and Neonatal Outcomes of In Vitro Fertilization-Embryo Transfer in Patient with Previous Cesarean Scar. | 27.3 | 0 | 2 |
| In Vitro Antioxidant Treatment of Semen Samples in Assisted Reproductive Technology: Effects of Myo-Inositol on Nemaspermic Parameters | 27.3 | 0 | 2 |
| Assisted reproduction and fertility preservation techniques in cancer patients | 27.3 | 0 | 2 |
| Clinical efficacy of body mass index as predictor of in vitro fertilization and embryo transfer outcomes | 27.3 | 0 | 2 |
| Optimizing natural fertility | 27.3 | 0 | 2 |
| Glycine supplementation in vitro enhances porcine preimplantation embryo cell number and decreases apoptosis but does not lead to live births | 27.3 | 0 | 2 |
| Comparison of easy and difficult embryo transfer outcomes in in vitro fertilization cycles | 27.3 | 0 | 2 |
| Heterotopic pregnancy following in vitro fertilization and embryo transfer: 12 cases report. | 27.3 | 0 | 2 |
| Application of in vitro maturation to assisted reproductive technology | 27.3 | 0 | 2 |
| Assisted reproductive technology use, embryo transfer practices, and birth outcomes after infertility insurance mandates: New Jersey and Connecticut | 27.3 | 0 | 2 |
| Costs of achieving live birth from assisted reproductive technology: a comparison of sequential single and double embryo transfer approaches | 27.3 | 0 | 2 |
| In vitro fertilisation (IVF) with donor eggs in post-menopausal women: are there differences in pregnancy outcomes in women with premature ovarian failure (POF) compared with women with physiological age-related menopause? | 27.3 | 0 | 2 |
| comparison between Cleavage Stage versus Blastocyst Stage Embryo Transfer in an Egyptian Cohort Undergoing in vitro Fertilization: A possible Role for Laser Assisted Hatching | 27.3 | 0 | 2 |
| Reduced protein C Global assay level in infertile women prior to IVF-ET treatment | 27.3 | 0 | 2 |
| Improvement of pregnancy rate by intrauterine administration of dexamethasone and recombinant human leukemia inhibitory factor at the time of embryo transfer in cattle | 27.3 | 0 | 2 |
| Efficacy of combined contraceptive vaginal ring versus oral contraceptive pills in achieving hypothalamic-pituitary-ovarian axis suppression in egg donor in vitro fertilization cycles | 27.3 | 0 | 2 |
| Effect of intrauterine injection of human chorionic gonadotropin before embryo transfer on clinical pregnancy rates from in vitro fertilisation cycles: a prospective study | 27.3 | 0 | 2 |
| Pregnancy Rate after First Intra Cytoplasmic Sperm Injection- In Vitro Fertilisation Cycle in Patients with Endometrioma with or without Deep Infiltrating Endometriosis | 27.3 | 0 | 2 |
| Validation of infertility treatment and assisted reproductive technology use on the birth certificate in eight states | 27.3 | 0 | 2 |
| Quality of embryos transferred and progesterone levels are the most important predictors of live birth after fresh embryo transfer: a retrospective cohort study | 27.3 | 0 | 2 |
| Fertility preservation with immature and in vitro matured oocytes | 27.3 | 0 | 2 |
| Economics of assisted reproduction: access to fertility treatments and valuing live births in economic terms | 27.3 | 0 | 2 |
| Hysterectomy in the Second Trimester of Pregnancy after In vitro Fertilization-embryo Transfer: A Case Report and Analysis of Its Risk Factors | 27.3 | 0 | 2 |
| Relationship of serum progesterone (P) level the day after human chorionic gonadotropin (hCG) injection on outcome following in vitro fertilization-embryo transfer (IVF-ET). | 27.3 | 0 | 2 |
| Severe systemic candidiasis following immunomodulation therapy in in vitro fertilisation-embryo transfer (IVF-ET) | 27.3 | 0 | 2 |
| Attitudes towards single embryo transfer, twin and higher order pregnancies in patients undergoing infertility treatment: a review | 27.3 | 0 | 2 |
| Inositol and In Vitro Fertilization with Embryo Transfer | 27.3 | 0 | 2 |
| Cumulative live-birth rates after assisted reproductive technology | 27.3 | 0 | 2 |
| Blastocyst Transfer Ameliorates Live Birth Rate Compared with Cleavage-Stage Embryos Transfer in FreshIn VitroFertilization or Intracytoplasmic Sperm Injection Cycles: Reviews and Meta-Analysis | 27.3 | 0 | 2 |
| Human immunodeficiency virus and infertility treatment | 27.3 | 0 | 2 |
| Effect of Antioxidants (β-mercaptoethanol and Cysteamine) on Assisted Reproductive Technology In vitro | 27.3 | 0 | 2 |
| Random start or emergency IVF/in vitro maturation: a new rapid approach to fertility preservation | 27.3 | 0 | 2 |
| Improving fertility preservation for girls and women by coupling oocyte in vitro maturation with existing strategies | 27.3 | 0 | 2 |
| Luteal phase oocyte retrieval and in vitro maturation is an optional procedure for urgent fertility preservation | 27.3 | 0 | 2 |
| In vitro fertilization-embryo transfer in nonhuman primates: the technique and its applications | 27.3 | 0 | 2 |
| Fertility preservation and infertility treatment in breast cancer patients | 27.3 | 0 | 2 |
| In vitro maturation of oocytes as a strategy for fertility preservation | 27.3 | 0 | 2 |
| Ectopic pregnancy following in vitro fertilisation and embryo transfer. | 27.3 | 0 | 2 |
| Does serologic evidence of remote Chlamydia trachomatis infection and its heat shock protein (CHSP 60) affect in vitro fertilization-embryo transfer outcome? | 27.3 | 0 | 2 |
| Infection control considerations for in vitro fertilization and embryo transfer programs | 27.3 | 0 | 2 |
| Full in vitro fertilization laboratory mechanization: toward robotic assisted reproduction? | 27.3 | 0 | 2 |
| Intracytoplasmic sperm injection (ICSI) for non-male factor infertility: a committee opinion | 27.3 | 0 | 2 |
| New Trends in Female Fertility Preservation: In Vitro Maturation of Oocytes | 27.3 | 0 | 2 |
| Term delivery following tuboovarian abscess after in vitro fertilization and embryo transfer | 27.3 | 0 | 2 |
| Ovarian stem cells—Potential roles in infertility treatment and fertility preservation | 27.3 | 0 | 2 |
| The wobbly evidence base of reproductive medicine | 27.3 | 0 | 2 |
| In Vitro Activation of Dormant Follicles for Fertility Preservation | 27.3 | 0 | 2 |
| The role of ultrasonography in in-vitro fertilization and embryo transfer (IVF-ET) | 27.3 | 0 | 2 |
| Misconduct in third-party assisted reproduction: a committee opinion | 27.3 | 0 | 2 |
| Cervical mucus removal before embryo transfer in women undergoing in vitro fertilization/intracytoplasmic sperm injection: a systematic review and meta-analysis of randomized controlled trials. | 27.3 | 0 | 2 |
| Clinical rationale for cryopreservation of entire embryo cohorts in lieu of fresh transfer | 27.3 | 0 | 2 |
| Cryopreservation and delayed embryo transfer-assisted reproductive technology registry and reporting implications | 27.3 | 0 | 2 |
| Acupuncture in IVF: A review of current literature | 27.3 | 0 | 2 |
| Recommended practices for the management of embryology, andrology, and endocrinology laboratories: a committee opinion | 27.3 | 0 | 2 |
| Assisted reproductive technology - IVF treatment in Ireland: A study of couples with successful outcomes | 27.3 | 0 | 2 |
| Does weight loss in overweight or obese women improve fertility treatment outcomes? A systematic review | 27.3 | 0 | 2 |
| Gonadotropin-releasing hormone antagonist and metformin for treatment of polycystic ovary syndrome patients undergoing in vitro fertilization-embryo transfer | 27.3 | 0 | 2 |
| In Vitro Maturation and Its Role in Clinical Assisted Reproductive Technology | 27.3 | 0 | 2 |
| Methods employed to overcome difficult embryo transfer during assisted reproduction treatment | 27.3 | 0 | 2 |
| Childlessness, parental mortality and psychiatric illness: a natural experiment based on in vitro fertility treatment and adoption | 27.3 | 0 | 2 |
| The importance of the length of uterine cavity, the position of the tip of the inner catheter and the distance between the fundal endometrial surface and the air bubbles as determinants of the pregnancy rate in IVF cycles | 27.3 | 0 | 2 |
| Role of tubal surgery in the era of assisted reproductive technology: a committee opinion | 27.3 | 0 | 2 |
| Clinical aspects of 7 pregnancies following in vitro fertilization and embryo transfer (IVF/ET) | 27.3 | 0 | 2 |
| Evidence of impaired endometrial receptivity after ovarian stimulation for in vitro fertilization: a prospective randomized trial comparing fresh and frozen–thawed embryo transfer in normal responders | 27.3 | 0 | 2 |
| Influence of well defined protein source on in vitro maturation of human oocyte: human follicular fluid versus human serum albumin | 27.3 | 0 | 2 |
| Emergency fertility preservation for female patients with cancer: clinical perspectives | 27.3 | 0 | 2 |
| Clinical efficacy of the gonadotropin-releasing hormone antagonist, ganirelix, in Korean women undergoing controlled ovarian hyperstimulation for in vitro fertilization and embryo transfer with recombinant follicle-stimulating hormone | 27.3 | 0 | 2 |
| Treatment with piroxicam before embryo transfer increases the pregnancy rate after in vitro fertilization and embryo transfer | 27.3 | 0 | 2 |
| The clinical efficacy and efficiency of a 100-IU starting dose of recombinant follicle stimulating hormone (Puregon) in Korean women undergoing in vitro fertilization and embryo transfer | 27.3 | 0 | 2 |
| Role of the mental health professional in education and support of the medical staff | 27.3 | 0 | 2 |
| Influence of female age on pregnancy outcome in in vitro fertilization and embryo transfer patients undergoing intracytoplasmic sperm injection | 27.3 | 0 | 2 |
| Simultaneous program of natural-cycle in vitro fertilization and cryopreserved-thawed embryo transfer | 27.3 | 0 | 2 |
| The outcome of in vitro fertilization and embryo transfer in women with polycystic ovary syndrome failing to conceive after ovulation induction with exogenous gonadotropins | 27.3 | 0 | 2 |
| Subclinical hypothyroidism in the infertile female population: a guideline | 27.3 | 0 | 2 |
| In vitro fertilization and embryo transfer in domestic animals: applications in animals and implications for humans | 27.3 | 0 | 2 |
| Impact of equine assisted reproductive technologies (standard embryo transfer or intracytoplasmic sperm injection (ICSI) with in vitro culture and embryo transfer) on placenta and foal morphometry and placental gene expression. | 27.3 | 0 | 2 |
| Leptin and its potential interest in assisted reproduction cycles | 27.3 | 0 | 2 |
| Effect of music therapy on the anxiety levels and pregnancy rate of women undergoing in vitro fertilization-embryo transfer: A randomized controlled trial. | 27.3 | 0 | 2 |
| Heterotopic Pregnancy After In Vitro Fertilization and Embryo Transfer After Bilateral Total Salpingectomy/Tubal Ligation: Case Report and Literature Review | 27.3 | 0 | 2 |
| Correct coding for laboratory procedures during assisted reproductive technology cycles | 27.3 | 0 | 2 |
| In Vitro Activation: A Possible New Frontier for Treatment of Primary Ovarian Insufficiency | 27.3 | 0 | 2 |
| Psychological studies of in vitro fertilization/embryo transfer participants | 27.3 | 0 | 2 |
| The effect of peri-implantation administration of uterine relaxing agents in assisted reproduction treatment cycles: a systematic review and meta-analysis | 27.3 | 0 | 2 |
| Infertility in advanced reproductive age. Results of in vitro fertilization and embryo transfer according to the woman's age. | 27.3 | 0 | 2 |
| Maternal Racial and Ethnic Disparities in Neonatal Birth Outcomes With and Without Assisted Reproduction | 27.3 | 0 | 2 |
| Female fertility preservation strategies: cryopreservation and ovarian tissue in vitro culture, current state of the art and future perspectives | 27.3 | 0 | 2 |
| Fertility Treatment, Use of in Vitro Fertilization, and Time to Live Birth Based on Initial Provider Type | 27.3 | 0 | 2 |
| The effects of surgery for endometriosis on pregnancy outcomes following in vitro fertilization and embryo transfer: a systematic review and meta-analysis | 27.3 | 0 | 2 |
| Factors predicting double embryo implantation following double embryo transfer in assisted reproductive technology: implications for elective single embryo transfer | 27.3 | 0 | 2 |
| History of ABVD alters the number of oocytes vitrified after in vitro maturation in fertility preservation candidates | 27.3 | 0 | 2 |
| Guidance on the limits to the number of embryos to transfer: a committee opinion | 27.3 | 0 | 2 |
| Perinatal outcomes among singletons after assisted reproductive technology with single-embryo or double-embryo transfer versus no assisted reproductive technology | 27.3 | 0 | 2 |
| Embryo transfer simulation improves pregnancy rates and decreases time to proficiency in Reproductive Endocrinology and Infertility fellow embryo transfers | 27.3 | 0 | 2 |
| Ectopic pregnancy following in vitro fertilization with embryo transfer: A single-center experience during 15 years | 27.3 | 0 | 2 |
| RNA-Seq-Based Transcriptome Analysis of Changes in Gene Expression Linked to Human Pregnancy Outcome After In Vitro Fertilization—Embryo Transfer | 27.3 | 0 | 2 |
| Evaluation of genetic components in traits related to superovulation, in vitro fertilization, and embryo transfer in Holstein cattle. | 27.3 | 0 | 2 |
| Impact of monozygotic twinning on multiple births resulting from in vitro fertilization in the United States, 2006–2010 | 27.3 | 0 | 2 |
| Endometrial scratching for women with previous IVF failure undergoing IVF treatment | 27.3 | 0 | 2 |
| Urinary triclosan concentrations and early outcomes of in vitro fertilization-embryo transfer | 27.3 | 0 | 2 |
| Complicating common ideas about medical tourism: gender, class, and globality in Yemenis' international medical travel | 27.3 | 0 | 2 |
| Performing the embryo transfer: a guideline | 27.3 | 0 | 2 |
| Organization and computerized analysis of in vitro fertilization and embryo transfer programs | 27.3 | 0 | 2 |
| Fertility preservation and reproduction in patients facing gonadotoxic therapies: a committee opinion | 27.3 | 0 | 2 |
| Bed rest after embryo transfer negatively affects in vitro fertilization: a randomized controlled clinical trial | 27.3 | 0 | 2 |
| In vitro fertilization and embryo transfer in Egypt | 27.3 | 0 | 2 |
| Patient selection for in vitro fertilization (IVF) and embryo transfer (ET). | 27.3 | 0 | 2 |
| Comparative analysis of in vitro fertilization methods for establishing successful embryo transfer clinics | 27.3 | 0 | 2 |
| Some legal implications of embryo transfer | 27.3 | 0 | 2 |
| Predicting personalized multiple birth risks after in vitro fertilization-double embryo transfer | 27.3 | 0 | 2 |
| Contributions of in vitro fertilization to knowledge of the reproductive endocrinology of the menstrual cycle | 27.3 | 0 | 2 |
| Problems related to the laboratory part of treatment by in vitro fertilization and embryo transfer. | 27.3 | 0 | 2 |
| A glance into the uterus during in vitro simulation of embryo transfer | 27.3 | 0 | 2 |
| Assisted reproductive technology: public funding and the voluntary shift to single embryo transfer in Australia | 27.3 | 0 | 2 |
| Normal birth after single-embryo transfer in a patient with excessive polypronuclear zygote formation following in vitro fertilization and intracytoplasmic sperm injection | 27.3 | 0 | 2 |
| Promoting medical tourism to India: messages, images, and the marketing of international patient travel | 27.3 | 0 | 2 |
| In vitro maturation and fertilization of vitrified immature human oocytes, subsequent vitrification of produced embryos, and embryo transfer after thawing | 27.3 | 0 | 2 |
| Ovarian stimulation with clomiphene and/or human menopausal gonadotropin (HMG) for in vitro fertilization (IVF) and embryo transfer (ET). | 27.3 | 0 | 2 |
| Ultrasound‐guided aspiration of hydrosalpinx occurring during controlled ovarian hyperstimulation could improve clinical outcome of in vitro fertilization–embryo transfer | 27.3 | 0 | 2 |
| Use of sexed sorted semen for fixed-time artificial insemination or fixed-time embryo transfer of in vitro–produced embryos in cattle | 27.3 | 0 | 2 |
| Intravenous intralipid therapy is not beneficial in having a live delivery in women aged 40-42 years with a previous history of miscarriage or failure to conceive despite embryo transfer undergoing in vitro fertilization-embryo transfer | 27.3 | 0 | 2 |
| In vitro maturation improves oocyte or embryo cryopreservation outcome in breast cancer patients undergoing ovarian stimulation for fertility preservation. | 27.3 | 0 | 2 |
| Assisted reproductive techniques in Latin America: the Latin American Registry, 2013 | 27.3 | 0 | 2 |
| Assisted reproductive medicine in Poland --Fertility and Sterility Special Interest Group of the Polish Gynaecological Society (SPiN PTG) 2012 report | 27.3 | 0 | 2 |
| Luteal-phase ovarian stimulation is a feasible method for poor ovarian responders undergoing in vitro fertilization/intracytoplasmic sperm injection-embryo transfer treatment compared to a GnRH antagonist protocol: A retrospective study | 27.3 | 0 | 2 |
| Pain during embryo transfer is independently associated with clinical pregnancy in fresh/frozen assisted reproductive technology cycles | 27.3 | 0 | 2 |
| Patients’ Evaluation of Intervention by a Medical Clown Visit or by Viewing a Humorous Film Following In Vitro Fertilization and Embryo Transfer | 27.3 | 0 | 2 |
| In vitro fertilization and embryo transfer program, Department of Obstetrics and Gynecology, University of Adelaide at the Queen Elizabeth Hospital, Woodville, South Australia | 27.3 | 0 | 2 |
| Position statement on West Nile virus: a committee opinion | 27.3 | 0 | 2 |
| Concepts in human in vitro fertilization and embryo transfer | 27.3 | 0 | 2 |
| Safety versus success in elective single embryo transfer: women's preferences for outcomes of in vitro fertilisation | 27.3 | 0 | 2 |
| In vitro maturation of germinal vesicle oocytes recovered after premature luteinizing hormone surge: description of a novel approach to fertility preservation | 27.3 | 0 | 2 |
| Risk of Coxiella burnetii transmission via embryo transfer using in vitro early bovine embryos | 27.3 | 0 | 2 |
| In vitro fertilization: problems in culture conditions and embryo transfer. | 27.3 | 0 | 2 |
| History of biochemical pregnancy was associated with the subsequent reproductive failure among women with recurrent spontaneous abortion | 27.3 | 0 | 2 |
| Can dicoumarol be used as a gonad-safe anticancer agent: anin vitroandin vivoexperimental study | 27.3 | 0 | 2 |
| In vitro fertilization and embryo transfer | 27.3 | 0 | 2 |
| Current status of in vitro fertilization and embryo transfer in man. | 27.3 | 0 | 2 |
| Mitochondrial D-loop Variations in Infertile Women Undergoing in Vitro Fertilization-Embryo Transfer | 27.3 | 0 | 2 |
| Obstetrics and gynecology: in vitro fertilization and embryo transfer | 27.3 | 0 | 2 |
| Recommendations for practices utilizing gestational carriers: a committee opinion | 27.3 | 0 | 2 |
| Is there an effect of thyroid autoimmunity on the outcomes of assisted reproduction? | 27.3 | 0 | 2 |
| American Society for Reproductive Medicine/Society for Assisted Reproductive Technology position statement on West Nile virus | 27.3 | 0 | 2 |
| T-helper 2 and 3 type immunity to trophoblast in successful in vitro fertilization-embryo transfer | 27.3 | 0 | 2 |
| Fertility preservation and reproduction in cancer patients | 27.3 | 0 | 2 |
| Low-versus high-dose human menopausal gonadotropin in an in vitro fertilization-embryo transfer program | 27.3 | 0 | 2 |
| Retrospective analysis of 6 cases of miliary tuberculosis in pregnant women after in vitro fertilization and embryo transfer | 27.3 | 0 | 2 |
| American Society for Reproductive Medicine/Society for Assisted Reproductive Technology position statement on West Nile virus | 27.3 | 0 | 2 |
| Heterotopic pregnancy following administration of human menopausal gonadotropin and following in vitro fertilization and embryo transfer: two case reports and review of the literature | 27.3 | 0 | 2 |
| Risk of ectopic pregnancy is linked to endometrial thickness in a retrospective cohort study of 8120 assisted reproduction technology cycles | 27.3 | 0 | 2 |
| Mid-luteal phase injection of subcutaneous leuprolide acetate improves live delivered pregnancy and implantation rates in younger women undergoing in vitro fertilization-embryo transfer (IVF-ET). | 27.3 | 0 | 2 |
| The poor-responder patient in an in vitro fertilization-embryo transfer (IVF-ET) program | 27.3 | 0 | 2 |
| American Society for Reproductive Medicine/Society for Assisted Reproductive Technology position statement on West Nile Virus | 27.3 | 0 | 2 |
| Progress of research on in vitro fertilization and embryo transfer in China. | 27.3 | 0 | 2 |
| Cumulative number and morphological score of embryos resulting in success: realistic expectations from in vitro fertilization-embryo transfer | 27.3 | 0 | 2 |
| Use of recombinant human follicle-stimulating hormone for in vitro fertilization-embryo transfer after severe systemic immunoglobulin E-mediated reaction to urofollitropin | 27.3 | 0 | 2 |
| High dosages of gonadotropins are associated with poor pregnancy outcomes after in vitro fertilization-embryo transfer. | 27.3 | 0 | 2 |
| Estimating cumulative live-birth rates after IVF treatment with Kaplan–Meier and competing risk methods | 27.3 | 0 | 2 |
| Placental development during early pregnancy in sheep: estrogen and progesterone receptor messenger RNA expression in pregnancies derived from in vivo–produced and in vitro–produced embryos | 27.3 | 0 | 2 |
| In vitro fertilization outcome relative to embryo transfer difficulty: a novel approach to the forbidding cervix. | 27.3 | 0 | 2 |
| Position on reproductive donors and smallpox vaccine: a committee opinion | 27.3 | 0 | 2 |
| Reduced Circulating Concentration of Brain‐derived Neurotrophic Factor is Associated with Peri‐ and Post‐implantation Failure following In Vitro Fertilization–Embryo Transfer | 27.3 | 0 | 2 |
| The influence of number of embryos transferred on pregnancy outcome in women undergoing in vitro fertilization and embryo transfer (IVF-ET). | 27.3 | 0 | 2 |
| Significance of an abnormal response during pituitary desensitization in an in vitro fertilization and embryo transfer program | 27.3 | 0 | 2 |
| Hormonal and Clinical Predictors for Post-egg Retrieval Pain in Women Undergoing Assisted Reproductive Technology Procedures. | 27.3 | 0 | 2 |
| Stability of in vitro fertilization-embryo transfer success rates from the 1989, 1990, and 1991 Clinic-Specific Outcome Assessments | 27.3 | 0 | 2 |
| Current differences and consequences of legislation on practice of assisted reproductive technology in the Nordic countries. The Nordic Committee on Assisted Reproduction of the Scandinavian Federation of Societies of Obstetrics and Gynecology | 27.3 | 0 | 2 |
| Effect of Methotrexate or Salpingectomy for Ectopic Pregnancy on Subsequent In Vitro Fertilization–Embryo Transfer Outcomes | 27.3 | 0 | 2 |
| Effects of high progesterone on outcomes ofin vitrofertilization-embryo transfer in patients with different ovarian responses | 27.3 | 0 | 2 |
| Predictive value of maternal serum human chorionic gonadotropin levels in pregnancies achieved by in vitro fertilization with single cleavage and single blastocyst embryo transfers | 27.3 | 0 | 2 |
| The single or dual administration of the gonadotropin-releasing hormone antagonist Cetrorelix in an in vitro fertilization-embryo transfer program. | 27.3 | 0 | 2 |
| Ectopic pregnancies after in vitro fertilization and embryo transfer. | 27.3 | 0 | 2 |
| Cornual pregnancies in patients with prior salpingectomy undergoing in vitro fertilization and embryo transfer. | 27.3 | 0 | 2 |
| Factors affecting occurrence of twin pregnancy after double embryo transfer on day 3 | 27.3 | 0 | 2 |
| Very early pregnancy wastage in in vitro fertilization and embryo transfer (IVF-ET). | 27.3 | 0 | 2 |
| The prognostic value and significance of preclinical abortions in in vitro fertilization-embryo transfer programs. | 27.3 | 0 | 2 |
| Comparison of live-birth defects after luteal-phase ovarian stimulation vs. conventional ovarian stimulation for in vitro fertilization and vitrified embryo transfer cycles | 27.3 | 0 | 2 |
| Cocultures in human assisted reproduction. Support of embryos in vitro and their specificity | 27.3 | 0 | 2 |
| Current technology of in vitro fertilization and embryo transfer. | 27.3 | 0 | 2 |
| Human immunodeficiency virus (HIV) and infertility treatment: a committee opinion | 27.3 | 0 | 2 |
| Fertilization in vitro and embryo transfer (FIVET) and endometriosis. Uncertainties and issues | 27.3 | 0 | 2 |
| Effects of two human chorionic gonadotropin doses administered to the ovarian states during the in vitro fertilization and embryo transfer program | 27.3 | 0 | 2 |
| Transport of wild mice genetic material by in vitro fertilization, cryopreservation, and embryo transfer | 27.3 | 0 | 2 |
| Attitudes toward egg donation of thirty-four infertile women who donated during their in vitro fertilization treatment | 27.3 | 0 | 2 |
| Safety in reproductive medicine: breadth, depth and discovery | 27.3 | 0 | 2 |
| Factors influencing pregnancy rates following in vitro fertilization and embryo transfer | 27.3 | 0 | 2 |
| A new form of communication between rheumatology and primary care: The virtual consultation | 27.3 | 0 | 2 |
| The effect of porcine relaxin vaginally applied at human embryo transfer in an in vitro fertilization programme | 27.3 | 0 | 2 |
| Failure of implantation in human in vitro fertilization and embryo transfer patients: the effects of altered progesterone/estrogen ratios in humans and mice. | 27.3 | 0 | 2 |
| Influence of male age on the pregnancy outcomes of IVF-ET | 27.3 | 0 | 2 |
| Delayed appearance of plasmatic chorionic gonadotropin in pregnancies after in vitro fertilization and embryo transfer | 27.3 | 0 | 2 |
| Fertility preservation for trans men: frozen-thawed in vitro matured oocytes collected at the time of ovarian tissue processing exhibit normal meiotic spindles | 27.3 | 0 | 2 |
| Fertility preservation in women of the childbearing age: Indications and strategies | 27.3 | 0 | 2 |
| Assisted reproductive techniques in single women: Which proposals for which demands? | 27.3 | 0 | 2 |
| Cryopreservation ofin vitromatured oocytes in addition to ovarian tissue freezing for fertility preservation in paediatric female cancer patients before and after cancer therapy | 27.3 | 0 | 2 |
| Successful elective and medically indicated oocyte vitrification and warming for autologous in vitro fertilization, with predicted birth probabilities for fertility preservation according to number of cryopreserved oocytes and age at retrieval | 27.3 | 0 | 2 |
| Can repeated IVF–ICSI-cycles be avoided by using blastocysts developing from poor-quality cleavage stage embryos? | 27.3 | 0 | 2 |
| Implantation of fresh and thawed–warmed embryos in single embryo transfer cycles: interpreting the initial beta-HCG | 27.3 | 0 | 2 |
| Developmental potential of zona pellucida–free oocytes obtained following mild in vitro fertilization | 27.3 | 0 | 2 |
| In vitro oocyte maturation for female fertility preservation | 27.3 | 0 | 2 |
| Birth of a domestic cat kitten produced by vitrification of lipid polarized in vitro matured oocytes | 27.3 | 0 | 2 |
| Optimal vitrification protocol for mouse ovarian tissue cryopreservation: effect of cryoprotective agents and in vitro culture on vitrified-warmed ovarian tissue survival | 27.3 | 0 | 2 |
| Mature oocyte cryopreservation: a guideline | 27.3 | 0 | 2 |
| Vitrification of oocytes for in vitro fertilization and embryo transfer | 27.3 | 0 | 2 |
| Efficacy of embryo transfer in lactating dairy cows during summer using fresh or vitrified embryos produced in vitro with sex-sorted semen | 27.3 | 0 | 2 |
| Efficacy of in vitro embryo transfer in lactating dairy cows using fresh or vitrified embryos produced in a novel embryo culture medium | 27.3 | 0 | 2 |
| Retrieval of immature oocytes from unstimulated ovaries followed by in vitro maturation and vitrification: A novel strategy of fertility preservation for breast cancer patients | 27.3 | 0 | 2 |
| Combining ovarian tissue cryobanking with retrieval of immature oocytes followed by in vitro maturation and vitrification: an additional strategy of fertility preservation | 27.3 | 0 | 2 |
| Retrieval of immature oocytes followed by in vitro maturation and vitrification: a case report on a new strategy of fertility preservation in women with borderline ovarian malignancy | 27.3 | 0 | 2 |
| Vitrification of human cleaved embryos in vitro fertilization-embryo transfer | 27.3 | 0 | 2 |
| Live births after vitrification of oocytes in a stimulated in vitro fertilization-embryo transfer program | 27.3 | 0 | 2 |
| Pregnancy rates following timed embryo transfer with fresh or vitrified in vitro produced embryos in lactating dairy cows under heat stress conditions | 27.3 | 0 | 2 |
| Economic evaluation of elective single-embryo transfer with subsequent single frozen embryo transfer in an in vitro fertilization/intracytoplasmic sperm injection program | 27.3 | 0 | 2 |
| Lapse in embryo transfer training does not negatively affect clinical pregnancy rates for reproductive endocrinology and infertility fellows | 27.3 | 0 | 2 |
| Sibling embryo blastocyst development correlates with the in vitro fertilization day 3 embryo transfer pregnancy rate in patients under age 40. | 27.3 | 0 | 2 |
| Efficacy of the Levonorgestrel-Releasing Intrauterine System on IVF-ET Outcomes in PCOS With Simple Endometrial Hyperplasia | 27.3 | 0 | 2 |
| Secondary donation of frozen embryos is more common after pregnancy initiation with donated eggs than after in vitro fertilization-embryo transfer and gamete intrafallopian transfer | 27.3 | 0 | 2 |
| Depression and coping strategies of Chinese women undergoing in-vitro fertilization | 27.3 | 0 | 2 |
| Superovulation-induced transient hyperprolactinemia in human in vitro fertilization and embryo transfer | 27.3 | 0 | 2 |
| Possibilities of ultrasound in the study of endometrial changes in cycle stimulation in the fertilization in vitro and embryo transfer programs | 27.3 | 0 | 2 |
| Medical sociology as a heuristic instrument for medical tourism and cross-border healthcare Comment on "International patients on operation vacation – perspectives of patients travelling to Hungary for orthopedic treatments" | 27.3 | 0 | 2 |
| A Case of Unicornuate Uterus with Atypical Located Hyperstimulated Ovary after in Vitro Fertilization Pre-Embryo Transfer (IVF-ET). | 27.3 | 0 | 2 |
| Obstetrics and gynecology-important advances in clinical medicine: human in vitro fertilization and embryo transfer. | 27.3 | 0 | 2 |
| Heterotopic pregnancy associated with in vitro fertilization and embryo transfer: a possible role for routine vaginal ultrasound | 27.3 | 0 | 2 |
| Recommendations for development of an emergency plan for in vitro fertilization programs: a committee opinion | 27.3 | 0 | 2 |
| Heterotopic pregnancies after in vitro fertilization and embryo transfer | 27.3 | 0 | 2 |
| The impact of spermatic vein ligation on the male factor in in vitro fertilization-embryo transfer and its relation to testosterone levels before and after operation | 27.3 | 0 | 2 |
| Ovarian stimulation and corpus luteum function in human in vitro fertilization and embryo transfer | 27.3 | 0 | 2 |
| Hepatitis B virus infection reduces fertilization ability during in vitro fertilization and embryo transfer | 27.3 | 0 | 2 |
| Corrigendum to "In Vitro Antioxidant Treatment of Semen Samples in Assisted Reproductive Technology: Effects of Myo-Inositol on Nemaspermic Parameters". | 27.3 | 0 | 2 |
| Tiaogeng Yijing decoction improves the pregnancy outcomes of patients with poor ovarian response undergoing in vitro fertilization-embryo transfer | 27.3 | 0 | 2 |
| Fertility Treatments in the United States: Improving Access and Outcomes | 27.3 | 0 | 2 |
| When looks are deceiving—the challenge facing embryo quality prognosticators | 27.3 | 0 | 2 |
| Telomerase activity is more significant for predicting the outcome of IVF treatment than telomere length in granulosa cells | 27.3 | 0 | 2 |
| Luteal phase following oocyte aspiration, in vitro fertilization, and embryo transfer in clomid/HCG-stimulated cycles | 27.3 | 0 | 2 |
| Prospective evaluation of basal stromal Doppler studies in women with good ovarian reserve and infertility undergoing in vitro fertilization-embryo transfer treatment: patients with polycystic ovary syndrome versus ovulatory patients. | 27.3 | 0 | 2 |
| Follicular fluid steroid content and in vitro steroid secretion by granulosa-lutein cells from individual follicles among different stimulation protocols for in vitro fertilization-embryo transfer | 27.3 | 0 | 2 |
| Prognosis of oocyte donation cycles: a prospective comparison of the in vitro fertilization-embryo transfer cycles of recipients who used shared oocytes versus those who used altruistic donors | 27.3 | 0 | 2 |
| Comparison of pregnancy rates following in vitro fertilization-embryo transfer between the donors and the recipients in a donor oocyte program | 27.3 | 0 | 2 |
| Physicians should be more open-minded about performing in vitro fertilization-embryo transfer in women with diminished oocyte reserve and consider the couple's wishes and desires | 27.3 | 0 | 2 |
| IVF Treatment and Single Embryo Transfer | 27.3 | 0 | 2 |
| Modified Natural Cycle for In Vitro Fertilization and Embryo Transfer in Normal Ovarion Responders | 27.3 | 0 | 2 |
| Effects of body mass index and age on the treatment of in vitro fertilization-embryo transfer among patients with non-polycystic ovarian syndrome | 27.3 | 0 | 2 |
| Association of the change in serum estradiol (E2) levels from the day of to the day after human chorionic gonadotropin (hCG) injection and pregnancy outcome following in vitro fertilization-embryo transfer (IVF-ET) in less than average responders | 27.3 | 0 | 2 |
| Use of recombinant human luteinizing hormone for ovulation stimulation in in vitro fertilization-embryo transfer | 27.3 | 0 | 2 |
| Comparison of Alarelin and Triptorelin in the long-protocol ovulation induction in in vitro fertilization and embryo transfer | 27.3 | 0 | 2 |
| A prospective clinical study of interventional ultrasound sclerotherapy on women with hydrosalpinx before in vitro fertilization and embryo transfer | 27.3 | 0 | 2 |
| Tubercular Ascites Simulating Ovarian Hyperstimulation Syndrome following In Vitro Fertilization and Embryo Transfer Pregnancy. | 27.3 | 0 | 2 |
| Efficacy of the International Embryo Transfer Society (IETS) washing procedure for rendering oocytes matured in vitro free of bovine viral diarrhea virus (BVDV) | 27.3 | 0 | 2 |
| In vitro fertilisation for all? Fertility treatment may be an economic blessing | 27.3 | 0 | 2 |
| Assisted reproduction: an important review of the literature on the risk of malformation after in vitro fertilization and intracytoplasmic sperm injection | 27.3 | 0 | 2 |
| Effect of er'zhi tiangui granule on metabonomics and level of Ca2+ in follicle fluid in patients after in vitro fertilization and embryo transfer | 27.3 | 0 | 2 |
| Crinone vaginal gel is equally effective and better tolerated than intramuscular progesterone for luteal phase support in in vitro fertilization–embryo transfer cycles: a prospective randomized study | 27.3 | 0 | 2 |
| Intramuscular vs intravaginal natural progesterone in patients undergoing in vitro fertilization-embryo transfer cycles. A retrospective observational, case-control study | 27.3 | 0 | 2 |
| Pregnancy outcome following in vitro fertilization-embryo transfer (IVF-ET) in women aged < 37, undergoing ovulation induction with human FSH compared with recombinant FSH: a randomised controlled study | 27.3 | 0 | 2 |
| Reproduction after breast cancer | 27.3 | 0 | 2 |
| Ovarian stimulation and emergency in vitro fertilization for fertility preservation in cancer patients | 27.3 | 0 | 2 |
| Effects of electroacupuncture on in vitro fertilization-embryo transfer (IVF-ET) of patients with poor ovarian response | 27.3 | 0 | 2 |
| Tubal ectopic pregnancy after in vitro fertilization and embryo transfer: a role for proximal occlusion or salpingectomy after failed distal tubal surgery? | 27.3 | 0 | 2 |
| Live birth of healthy triplets after in vitro fertilization and embryo transfer in an acromegalic woman with elevated growth hormone | 27.3 | 0 | 2 |
| Immunosuppressive activity in human in vitro fertilization (IVF) culture supernatants and prediction of the outcome of embryo transfer: a multicenter trial | 27.3 | 0 | 2 |
| Luteal phase support for in vitro fertilization-embryo transfer--present and future methods to improve successful implantation | 27.3 | 0 | 2 |
| Refuting a misguided campaign against the goal of single-embryo transfer and singleton birth in assisted reproduction | 27.3 | 0 | 2 |
| Twin classics: research that always inspires/Twin studies: elder twin relationships; Superfecundated twinning in chimpanzees; Conjoined twinning and embryo transfer; Reduced frequency of in vitro multiples/Professional and human interest: first iden | 27.3 | 0 | 2 |
| First full-term pregnancy after in vitro fertilization and embryo reimplantation. The In Vitro Fertilization-Embryo Transfer Group of Torino | 27.3 | 0 | 2 |
| Perinatal morbidity after in vitro fertilization is lower with frozen embryo transfer | 27.3 | 0 | 2 |
| Singleton pregnancy outcomes after in vitro fertilization with fresh or frozen-thawed embryo transfer and incidence of placenta praevia. | 27.3 | 0 | 2 |
| Usage of herbal medications in patients undergoing IVF treatment in an Irish infertility treatment unit | 27.3 | 0 | 2 |
| Serum human chorionic gonadotropin levels are correlated with body mass index rather than route of administration in women undergoing in vitro fertilization--embryo transfer using human menopausal gonadotropin and intracytoplasmic sperm injection | 27.3 | 0 | 2 |
| Repetitive oocyte donation: a committee opinion | 27.3 | 0 | 2 |
| Morphology of seminal and swim-up spermatozoa and the outcome of in vitro fertilization and embryo transfer. | 27.3 | 0 | 2 |
| Assessment of follicular maturity by follicular diameter and fluid volume in a program of in vitro fertilization and embryo transfer | 27.3 | 0 | 2 |
| Society for Assisted Reproductive Technology/Centers for Disease Control and Prevention in vitro fertilization registry 2.0. | 27.3 | 0 | 2 |
| Relationship of antibodies to sperm head to etiology of infertility in patients undergoing in vitro fertilization/embryo transfer | 27.3 | 0 | 2 |
| Optimizing natural fertility: a committee opinion | 27.3 | 0 | 2 |
| Comparison of recombinant and urinary follicle-stimulating hormone preparations in short-term gonadotropin releasing hormone agonist protocol for in vitro fertilization-embryo transfer | 27.3 | 0 | 2 |
| Life after unsuccessful IVF treatment in an assisted reproduction unit: a qualitative analysis of gains through loss among Chinese persons in Hong Kong. | 27.3 | 0 | 2 |
| Increased progesterone/estradiol ratio in the late follicular phase could be related to low ovarian reserve in in vitro fertilization-embryo transfer cycles with a long gonadotropin-releasing hormone agonist | 27.3 | 0 | 2 |
| A prospective randomized study comparing intramuscular progesterone and 17alpha-hydroxyprogesterone caproate in patients undergoing in vitro fertilization-embryo transfer cycles | 27.3 | 0 | 2 |
| Effect of maternal height and weight on risk of preterm birth in singleton and twin births resulting from in vitro fertilization: a retrospective cohort study using the Society for Assisted Reproductive Technology Clinic Outcome Reporting System | 27.3 | 0 | 2 |
| Recommendations for reducing the risk of viral transmission during fertility treatment with the use of autologous gametes: a committee opinion | 27.3 | 0 | 2 |
| A case of multiple (5) ectopic pregnancies, ultimately resulting in a twin pregnancy after in vitro fertilization and embryo transfer | 27.3 | 0 | 2 |
| Case report: treatment of congenital vas obstruction with sperm aspiration, nonstimulated in vitro fertilization, and nonsurgical tubal embryo transfer | 27.3 | 0 | 2 |
| In vitro fertilization and embryo transfer at the community hospital in Arhus | 27.3 | 0 | 2 |
| A randomized study comparing Crinone 8% and intramuscular progesterone supplementation in in vitro fertilization-embryo transfer cycles | 27.3 | 0 | 2 |
| In vitro fertilization and embryo transfer: two-year experience | 27.3 | 0 | 2 |
| A Comparison of Immigrant and Canadian-Born Patients Seeking Fertility Treatment | 27.3 | 0 | 2 |
| Estimation of the Contribution of Assisted and Non-Assisted Reproductive Technology Fertility Treatments to Multiple Births During the Past 30 Years in Japan: 1979–2008 | 27.3 | 0 | 2 |
| Perinatal outcomes after assisted reproductive technology treatment in Australia and New Zealand: single versus double embryo transfer. | 27.3 | 0 | 2 |
| Policy positions on in vitro fertilization and embryo transfer in human individuals (German Democratic Republic, 1985). | 27.3 | 0 | 2 |
| Ectopic tubal pregnancy following in vitro fertilization and embryo transfer under ultrasonic control. | 27.3 | 0 | 2 |
| An analysis of factors associated with ectopic pregnancy following in vitro fertilization and embryo transfer | 27.3 | 0 | 2 |
| Serum prolactin response to embryo transfer during human in vitro fertilization and embryo transfer | 27.3 | 0 | 2 |
| Use of computer analysis in the program of in vitro fertilization and embryo transfer | 27.3 | 0 | 2 |
| The in vitro fertilization and embryo transfer program at the First Women's Hospital "T. Kirkova," Sofia, Bulgaria | 27.3 | 0 | 2 |
| Human in vitro fertilization and embryo transfer program at the Medical Academy, Sofia, Bulgaria | 27.3 | 0 | 2 |
| Transvaginal ultrasound-guided embryo transfer improves outcome in patients with previous failed in vitro fertilization cycles | 27.3 | 0 | 2 |
| Increased endometrial thickness on the day of human chorionic gonadotropin injection does not adversely affect pregnancy or implantation rates following in vitro fertilization-embryo transfer | 27.3 | 0 | 2 |
| Impact of Anticardiolipin Antibody on the Outcome of In Vitro Fertilization and Embryo Transfer | 27.3 | 0 | 2 |
| Evolution of a highly successful in vitro fertilization-embryo transfer program | 27.3 | 0 | 2 |
| Effects of the intensity of downregulation on outcome of in vitro fertilization and embryo transfer | 27.3 | 0 | 2 |
| Differences in steroidogenic acute regulatory protein expression from the luteinizing-granulosa cells of patients undergoing in vitro fertilization with embryo transfer: implications for cycle outcomes | 27.3 | 0 | 2 |
| Influence of EmbryoGlue on the implantation of embryo and pregnancy outcome in vitro fertilization-embryo transfer | 27.3 | 0 | 2 |
| Are implantation and pregnancy outcome impaired in diethylstilbestrol-exposed women after in vitro fertilization and embryo transfer? | 27.3 | 0 | 2 |
| Matched controlled study to evaluate the effect of endometrial polyps on pregnancy and implantation rates following in vitro fertilization-embryo transfer (IVF-ET) | 27.3 | 0 | 2 |
| The effect of smoking on infertility treatment in women undergoing assisted reproduction cycles | 27.3 | 0 | 2 |
| The cytology of vaginal, cervical and endometrial smears obtained at the time of embryo transfer during in vitro fertilization | 27.3 | 0 | 2 |
| The role of tubal pathology and other parameters in ectopic pregnancies occurring in in vitro fertilization and embryo transfer | 27.3 | 0 | 2 |
| Effect of prolonged gonadotropin-releasing hormone agonist therapy on the outcome of in vitro fertilization-embryo transfer in patients with endometriosis | 27.3 | 0 | 2 |
| Cycle-specific and cumulative fecundity in patients with endometriosis who are undergoing controlled ovarian hyperstimulation-intrauterine insemination or in vitro fertilization-embryo transfer | 27.3 | 0 | 2 |
| Influence of severe endometriosis on gene expression of vascular endothelial growth factor and interleukin-6 in granulosa cells from patients undergoing controlled ovarian hyperstimulation for in vitro fertilization-embryo transfer | 27.3 | 0 | 2 |
| Deletion of chromosome 4: 46,XY, del(4) (q31.3) after gamete intrafallopian transfer and in vitro fertilization-embryo transfer | 27.3 | 0 | 2 |
| Comparison of singleton and multiple pregnancies in in vitro fertilization (IVF) and embryo transfer (ET). | 27.3 | 0 | 2 |
| Dummy embryo transfer: a technique that minimizes the problems of embryo transfer and improves the pregnancy rate in human in vitro fertilization | 27.3 | 0 | 2 |
| Delayed fertilization during in vitro fertilization and embryo transfer cycles: analysis of causes and impact on overall results. | 27.3 | 0 | 2 |
| Impact of high response of ovary to gonadotropin stimulation on the outcome of in vitro fertilization and embryo transfer or intracytoplasmic sperm injection | 27.3 | 0 | 2 |
| In Vitro Fertilization of Preovulatory Oocytes and Embryo Transfer in Infertile Patients Treated with Clomiphene and Human Chorionic Gonadotropin | 27.3 | 0 | 2 |
| The effect of endometriosis on pregnancy outcome following in vitro fertilization-embryo transfer (IVF-ET) in women with decreased egg reserve | 27.3 | 0 | 2 |
| Personal experience with ovarian stimulation in an in vitro fertilization and embryo transfer program | 27.3 | 0 | 2 |
| Relationship of antisperm antibodies to oocyte fertilization in in vitro fertilization-embryo transfer | 27.3 | 0 | 2 |
| Pregnancy-specific beta 1-glycoprotein (SP1) after in vitro fertilization and embryo transfer | 27.3 | 0 | 2 |
| The serum concentration of estradiol after embryo transfer and the decline from preovulatory levels may influence the success of IVF treatment | 27.3 | 0 | 2 |
| An ectopic pregnancy in the upper retroperitoneum following in vitro fertilization and embryo transfer. | 27.3 | 0 | 2 |
| Injection of day 2 embryo culture supernatant into the uterine cavity did not improve the pregnancy rate of day 3 embryo transfer in patients who underwent in vitro fertilization-embryo transfer: a randomized clinical trial | 27.3 | 0 | 2 |
| Salivary oestradiol and progesterone after in vitro fertilization and embryo transfer using different luteal support regimens | 27.3 | 0 | 2 |
| Prospective evaluation of two stimulation protocols for low responders who were undergoing in vitro fertilization–embryo transfer | 27.3 | 0 | 2 |
| Relationship between peak serum estradiol levels and treatment outcome in in vitro fertilization cycles after embryo transfer on day 3 or day 5. | 27.3 | 0 | 2 |
| Monitoring of in vitro fertilization-embryo transfer cycles by ultrasound versus by ultrasound and hormonal levels: a prospective, multicenter, randomized study. | 27.3 | 0 | 2 |
| Significantly lower ectopic pregnancy rates after frozen embryo transfer: implications toward segmentation of in vitro fertilization treatment | 27.3 | 0 | 2 |
| Effect of low-dose triptorelin on pituitary down-regulation for patients undergoing in vitro fertilization and embryo transfer | 27.3 | 0 | 2 |
| The results of a program of in vitro fertilization and tubal embryo transfer (ZIFT) | 27.3 | 0 | 2 |
| Intratubal transfer of an embryo or a zygote. (TET or GIFT) Past, present and future? Comparative study of tubal embryo transfer (TET) versus in vitro fertilization | 27.3 | 0 | 2 |
| Cumulus Cell Mitochondrial Resistance to Stress In Vitro Predicts Oocyte Development During Assisted Reproduction | 27.3 | 0 | 2 |
| Hypersensitivity to progesterone-in-oil after in vitro fertilization and embryo transfer | 27.3 | 0 | 2 |
| Two cases of systemic Candida glabrata infection following in vitro fertilization and embryo transfer | 27.3 | 0 | 2 |
| Treatment-independent, treatment-associated, and pregnancies after additional therapy in a program of in vitro fertilization and embryo transfer | 27.3 | 0 | 2 |
| Risk factors for ectopic pregnancy after in vitro fertilization and embryo transfer | 27.3 | 0 | 2 |
| Successful pregnancy after in vitro fertilization and embryo transfer from an infertile woman to a surrogate | 27.3 | 0 | 2 |
| Factors influencing successful in vitro fertilization and embryo transfer: a matched pair study | 27.3 | 0 | 2 |
| The influence of oocyte maturity and embryo quality on pregnancy rate in a program for in vitro fertilization-embryo transfer | 27.3 | 0 | 2 |
| Successful completion of pregnancy after fertilization in vitro and embryo transfer | 27.3 | 0 | 2 |
| Comparison of two different starting multiple dose gonadotropin-releasing hormone antagonist protocols in a selected group of in vitro fertilization-embryo transfer patients | 27.3 | 0 | 2 |
| Immunophenotypic profiles of peripheral blood lymphocytes on the day of embryo transfer in women undergoing in vitro fertilization | 27.3 | 0 | 2 |
| Maternal serum progesterone concentration and early conceptus development of bovine embryos produced in vivo or in vitro | 27.3 | 0 | 2 |
| Use of in vitro fertilization and embryo transfer to circumvent infertility caused by an inherited imperforate vagina in mice | 27.3 | 0 | 2 |
| Ultrasound guidance of embryo transfer: A role for midwife | 27.3 | 0 | 2 |
| Cumulative delivery rate in an in vitro fertilization program with a single embryo transfer policy | 27.3 | 0 | 2 |
| β-human chorionic gonadotropin as a monitor of pregnancy outcome in in vitro fertilization-embryo transfer patients | 27.3 | 0 | 2 |
| Embryo transfer to the uterus or the fallopian tube after in vitro fertilization yields similar results | 27.3 | 0 | 2 |
| Hepatitis B infection and outcomes of in vitro fertilization and embryo transfer treatment | 27.3 | 0 | 2 |
| Mock embryo transfer in early luteal phase, the cycle before in vitro fertilization and embryo transfer: a descriptive study | 27.3 | 0 | 2 |
| The window of embryo transfer and the efficiency of human conception in vitro. | 27.3 | 0 | 2 |
| In vitro fertilization and embryo transfer: an established and successful therapy for endometriosis | 27.3 | 0 | 2 |
| Gonadotropin stimulation for in vitro fertilization and embryo transfer in insulin-dependent diabetics: follicular response, oocyte quality, embryo development, and follicular environment | 27.3 | 0 | 2 |
| Correlative analysis of social support with anxiety and depression in men undergoing in vitro fertilization embryo transfer for the first time | 27.3 | 0 | 2 |
| Survival of the cornual pregnancy in a heterotopic gestation after in vitro fertilization and embryo transfer | 27.3 | 0 | 2 |
| Suboptimal laboratory conditions can affect pregnancy outcome after embryo transfer on day 1 or 2 after insemination in vitro | 27.3 | 0 | 2 |
| Utilization and success rates of unstimulated in vitro fertilization in the United States: an analysis of the Society for Assisted Reproductive Technology database | 27.3 | 0 | 2 |
| Ovarian stimulation for in vitro fertilization and embryo transfer, human menopausal gonadotropin versus pure human follicle stimulating hormone: a randomized prospective study. | 27.3 | 0 | 2 |
| Study on leuprorelin acetate in treatment of uterine adenomyosis with infertility | 27.3 | 0 | 2 |
| Comparison of clinical outcome of mild-stimulation and conventional ovarian stimulation in in vitro fertilization-embryo transfer (IVF-ET) | 27.3 | 0 | 2 |
| Serum beta human chorionic gonadotropin levels on day 12 after in vitro fertilization in predicting final type of clinical pregnancy | 27.3 | 0 | 2 |
| An assessment of alternative policies for embryo transfer in an in vitro fertilization-embryo transfer program | 27.3 | 0 | 2 |
| Effects of the severity of tubo-ovarian disease and previous tubal surgery on the results of in vitro fertilization and embryo transfer | 27.3 | 0 | 2 |
| Abdominal pregnancy after in vitro fertilization and embryo transfer | 27.3 | 0 | 2 |
| Monitoring gonadotropin-stimulated cycles for in vitro fertilization and embryo transfer | 27.3 | 0 | 2 |
| In vitro fertilization and embryo transfer (IVF/ET): an established and successful therapy for endometriosis | 27.3 | 0 | 2 |
| Spontaneous luteinizing hormone (LH) surges are associated with more rapidly increasing estradiol (E2) and follicle stimulating hormone (FSH) in in vitro fertilization and embryo transfer | 27.3 | 0 | 2 |
| The efficiency of human reproduction after in vitro fertilization and embryo transfer. | 27.3 | 0 | 2 |
| Mechanisms and factors of early pregnancy wastage in in vitro fertilization-embryo transfer patients. | 27.3 | 0 | 2 |
| Low-dose glucocorticoids after in vitro fertilization and embryo transfer have no significant effect on pregnancy rate. | 27.3 | 0 | 2 |
| Serum progesterone and estradiol concentrations in the early diagnosis of ectopic pregnancy after in vitro fertilization-embryo transfer | 27.3 | 0 | 2 |
| Evidence-based medicine and the role of the private sector in assisted reproduction: a response to Dr Fishel’s commentary ‘Evidenced-based medicine and the role of the National Health Service in assisted reproduction’ | 27.3 | 0 | 2 |
| Embryo transfer as a means of controlling the transmission of viral infections. IX. The in vitro exposure of zona pellucida-intact porcine embryos to swine vesicular disease virus | 27.3 | 0 | 2 |
| Impact of detection of bacterial endotoxin in menstrual effluent on the pregnancy rate in in vitro fertilization and embryo transfer | 27.3 | 0 | 2 |
| A 10-year survey on birth defects after in vitro fertilization-embryo transfer in Shanghai | 27.3 | 0 | 2 |
| Risk-sharing or refund programs in assisted reproduction: a committee opinion | 27.3 | 0 | 2 |
| Reproductive medicine and the law: egg donation in Germany, Spain and other European countries | 27.3 | 0 | 2 |
| Multivariate analysis of factors affecting probability of pregnancy and live birth with in vitro fertilization: an analysis of the Society for Assisted Reproductive Technology Clinic Outcomes Reporting System | 27.3 | 0 | 2 |
| The midluteal decline in serum estradiol levels is drastic but not deleterious for implantation after in vitro fertilization and embryo transfer in patients with normal or high responses | 27.3 | 0 | 2 |
| Isolation of seminal and vaginal bacteria from patients on a protocol of in vitro fertilization and embryo transfer | 27.3 | 0 | 2 |
| Increased endometrial thickness is associated with improved treatment outcome for selected patients undergoing in vitro fertilization-embryo transfer | 27.3 | 0 | 2 |
| Intrauterine candidiasis in a twin pregnancy after myomectomy, in vitro fertilization and embryo transfer | 27.3 | 0 | 2 |
| Misdiagnosis and delayed diagnosis for ectopic and heterotopic pregnancies after in vitro fertilization and embryo transfer | 27.3 | 0 | 2 |
| Embryo yield after in vitro fertilization in women undergoing embryo banking for fertility preservation before chemotherapy | 27.3 | 0 | 2 |
| Society for Assisted Reproductive Technology position statement on donor suitability of recipients of smallpox vaccine (vaccinia virus). | 27.3 | 0 | 2 |
| Can India save its Parsi community with assisted reproduction? | 27.3 | 0 | 2 |
| Society for Assisted Reproductive Technology position statement on donor suitability of recipients of smallpox vaccine (vaccinia virus). | 27.3 | 0 | 2 |
| Embryo transfer as a means of controlling the transmission of viral infections. XI. The in vitro exposure of bovine and porcine embryos to vesicular stomatitis virus | 27.3 | 0 | 2 |
| Embryo transfer as a means of controlling the transmission of viral infections. VII. The in vitro exposure of bovine and porcine embryos to foot-and-mouth disease virus | 27.3 | 0 | 2 |
| Embryo transfer as a means of controlling the transmission of viral infections. II. The in vitro exposure of preimplantation bovine embryos to infectious bovine rhinotracheitis virus | 27.3 | 0 | 2 |
| Relationship among serum levels of luteinizing hormone, estradiol, and progesterone during follicle stimulation and results of in vitro fertilization and embryo transfer (IVF-ET). | 27.3 | 0 | 2 |
| Human immunodeficiency virus and infertility treatment | 27.3 | 0 | 2 |
| Society for assisted reproductive technology position statement on donor suitability of recipients of smallpox vaccine (vaccinia virus). | 27.3 | 0 | 2 |
| Society for assisted reproductive technology position statement on donor suitability of recipients of smallpox vaccine (vaccinia virus). | 27.3 | 0 | 2 |
| Obstetrical and neonatal outcomes from the BEST Trial: single embryo transfer with aneuploidy screening improves outcomes after in vitro fertilization without compromising delivery rates | 27.3 | 0 | 2 |
| Human immunodeficiency virus and infertility treatment | 27.3 | 0 | 2 |
| Effect of domestic highly purified urinary follicle stimulating hormone on outcomes of in vitro fertilization-embryo transfer in controlled ovarian stimulation | 27.3 | 0 | 2 |
| Effects of early-cleavage embryo transfer on in vitro fertilization-embryo transfer pregnancy outcomes | 27.3 | 0 | 2 |
| In Vitro Fertilization and Embryo Transfer | 27.3 | 0 | 2 |
| Single curettage endometrial biopsy injury in the proliferative phase improves reproductive outcome of subsequent in vitro fertilization-embryo transfer cycle in infertile patients with repeated embryo implantation failure | 27.3 | 0 | 2 |
| Early primary abdominal pregnancy after in vitro fertilization and embryo transfer | 27.3 | 0 | 2 |
| Correlation between serum inhibin B level after treatment with gonadotropin releasing hormone agonist and outcome of in vitro fertilization-embryo transfer | 27.3 | 0 | 2 |
| Improving in vitro maturation and pregnancy outcome in cattle using a novel oocyte shipping and maturation system not requiring a CO2 gas phase | 27.3 | 0 | 2 |
| Guidelines on number of embryos transferred | 27.3 | 0 | 2 |
| Vaginal micronized progesterone versus intramuscular progesterone for luteal support in women undergoing in vitro fertilization-embryo transfer | 27.3 | 0 | 2 |
| A program for in vitro fertilization and embryo transfer at the Southern California Fertility Institute, Inc. | 27.3 | 0 | 2 |
| Modified super-long down-regulation protocol improved the outcome of in vitro fertilization-embryo transfer in infertile patients. | 27.3 | 0 | 2 |
| Public policy aspects of assisted reproduction. Vth World Congress, IVF and embryo transfer | 27.3 | 0 | 2 |
| Live birth of a normal mature healthy baby by in vitro fertilization-embryo transfer (IVF-ET) after an exploratory laparotomy and multiple myomectomy for leiomyomatosis peritonealis disseminata | 27.3 | 0 | 2 |
| Effect of polychlorinated biphenyls (PCBs) and 1,1,1-trichloro-2,2,-bis (4-chlorophenyl)-ethane (DDT) in follicular fluid on the results of in vitro fertilization-embryo transfer (IVF-ET) programs. | 27.3 | 0 | 2 |
| Effects of early luteal-phase vaginal progesterone supplementation on the outcome of in vitro fertilization and embryo transfer | 27.3 | 0 | 2 |
| Sonohysterography as a first-line evaluation for uterine abnormalities in women with recurrent failed in vitro fertilization-embryo transfer | 27.3 | 0 | 2 |
| Generating Transgenic Mice by Lentiviral Transduction of Spermatozoa Followed by In Vitro Fertilization and Embryo Transfer | 27.3 | 0 | 2 |
| Evaluation for the clinical application of all embryos cryopreservation: a multi-centre study in northern area of China | 27.3 | 0 | 2 |
| Legislative guidelines to govern in vitro fertilization and embryo transfer | 27.3 | 0 | 2 |
| Changes in serum cortisol and prolactin associated with acupuncture during controlled ovarian hyperstimulation in women undergoing in vitro fertilization-embryo transfer treatment | 27.3 | 0 | 2 |
| Impact of antiovarian antibodies (AOA) on ovarian responsiveness in vitro fertilization and embryo transfer | 27.3 | 0 | 2 |
| Fertility preservation for men with testicular cancer: Is sperm cryopreservation cost effective in the era of assisted reproductive technology? | 27.3 | 0 | 2 |
| Casting for determinants of blastocyst yield and of rates of implantation and of pregnancy after blastocyst transfers | 27.3 | 0 | 2 |
| Progesterone supplementation during the luteal phase and in early pregnancy in the treatment of infertility: an educational bulletin | 27.3 | 0 | 2 |
| Prognostic indicators of assisted reproduction technology outcomes of cycles with ultralow serum antimüllerian hormone: a multivariate analysis of over 5,000 autologous cycles from the Society for Assisted Reproductive Technology Clinic Outcome Repo | 27.3 | 0 | 2 |
| Ovarian stimulation, egg aspiration, in vitro fertilization and embryo transfer in the baboon (Papio anubis): a pilot project at the Institute of Primate Research, Nairobi, Kenya | 27.3 | 0 | 2 |
| Trends and factors associated with the Day 5 embryo transfer, assisted reproductive technology surveillance, USA, 2001-2009. | 27.3 | 0 | 2 |
| Submicroscopic mathematical evaluation of spermatozoa in assisted reproduction. 2. In vitro fertilization (notulae seminologicae. 7). | 27.3 | 0 | 2 |
| The effect of medical clowning on pregnancy rates after in vitro fertilization and embryo transfer | 27.3 | 0 | 2 |
| Rosacea fulminans in the early course of a pregnancy by in vitro fertilization with embryo transfer | 27.3 | 0 | 2 |
| In vitro maturation and surrogacy in patients with vascular-type Ehlers–Danlos syndrome – A safe assisted reproductive technology approach | 27.3 | 0 | 2 |
| Principles of medical ethics in the in vitro fertilization and embryo transfer program | 27.3 | 0 | 2 |
| World collaborative report on in vitro fertilization, 2000. | 27.3 | 0 | 2 |
| Simultaneous bilateral tubal pregnancy after in vitro fertilization and embryo transfer | 27.3 | 0 | 2 |
| Neonatal outcomes of pregnancy resulting from in vitro fertilization and embryo transfer: analysis of 1274 cases | 27.3 | 0 | 2 |
| Analysis of pregnancy outcomes after in vitro fertilization-embryo transfer and intracytoplasmic sperm injection | 27.3 | 0 | 2 |
| Slightly lower incidence of ectopic pregnancies in frozen embryo transfer cycles versus fresh in vitro fertilization-embryo transfer cycles: a retrospective cohort study | 27.3 | 0 | 2 |
| Short-term medical complications of 1500 oocyte retrievals for in vitro fertilization and embryo transfer | 27.3 | 0 | 2 |
| In vitro fertilization through egg donation: a prospective view of legal issues. | 27.3 | 0 | 2 |
| In Vitro Fertilisation and Embryo Transfer. | 27.3 | 0 | 2 |
| Bilateral tubal pregnancy following in vitro fertilization and embryo transfer | 27.3 | 0 | 2 |
| Simultaneous bilateral tubal pregnancies after in vitro fertilization and embryo transfer: report of a case | 27.3 | 0 | 2 |
| Leuprolide acetate reduces both in vivo and in vitro ovarian steroidogenesis in infertile women undergoing assisted reproduction. | 27.3 | 0 | 2 |
| Heterotopic pregnancy after in vitro fertilization and embryo transfer | 27.3 | 0 | 2 |
| Estrogen role in the luteal phase support in in vitro fertilization with embryo transfer cycles | 27.3 | 0 | 2 |
| Optimization of estradiol supplementation during the luteal phase improves the pregnancy rate in women undergoing in vitro fertilization-embryo transfer cycles | 27.3 | 0 | 2 |
| The first reported case of Down syndrome in the Southern California Fertility Institute's in vitro fertilization and embryo transfer program | 27.3 | 0 | 2 |
| Increased progesterone/estradiol ratio on the day of HCG administration adversely affects success of in vitro fertilization-embryo transfer in patients stimulated with gonadotropin-releasing hormone agonist and recombinant follicle-stimulating hormo | 27.3 | 0 | 2 |
| Further evidence on the safety and success of ovarian stimulation with letrozole and tamoxifen in breast cancer patients undergoing in vitro fertilization to cryopreserve their embryos for fertility preservation | 27.3 | 0 | 2 |
| Evolution of a reproductive endocrinologist: the Society for Reproductive Endocrinology and Infertility fellows retreat and preliminary results of manpower survey | 27.3 | 0 | 2 |
| In vitro fertilization and embryo transfer: Northridge Hospital Medical Center, California | 27.3 | 0 | 2 |
| Matched-samples comparison of intramuscular versus vaginal progesterone for luteal phase support after in vitro fertilization and embryo transfer | 27.3 | 0 | 2 |
| Embryo transfer practices in the United States: a survey of clinics registered with the Society for Assisted Reproductive Technology | 27.3 | 0 | 2 |
| Posthumous assisted reproduction: a survey of attitudes of couples seeking fertility treatment and the degree of agreement between intimate partners | 27.3 | 0 | 2 |
| Viral infections among couples for assisted reproduction in a fertility clinic in Nigeria. | 27.3 | 0 | 2 |
| Antral follicle count (AFC) can be used in the prediction of ovarian response but cannot predict the oocyte/embryo quality or the in vitro fertilization outcome in an egg donation program | 27.3 | 0 | 2 |
| Results of prednisolone given to improve the outcome of in vitro fertilization-embryo transfer in women with antinuclear antibodies | 27.3 | 0 | 2 |
| AB077. Relationship of TPO-Ab and TSH with in vitro fertilization and embryo transfer | 27.3 | 0 | 2 |
| Two successful pregnancies after in vitro fertilization and embryo transfer in a patient with endometrial atypical hyperplasia bordering on adenocarcinoma treated conservatively with high-dose progesterone | 27.3 | 0 | 2 |
| Validation of Correction Factors for Serum Markers for First-Trimester Down Syndrome Screening in Singleton Pregnancies Conceived with Assisted Reproduction | 27.3 | 0 | 2 |
| Factors associated with dizygotic twinning after IVF treatment with double embryo transfer | 27.3 | 0 | 2 |
| An in vitro fertilization and embryo transfer pilot study: treatment-dependent and treatment-independent pregnancies | 27.3 | 0 | 2 |
| Treatment period and medical care costs to achieve the first live birth by assisted reproductive technology are lower in the single embryo transfer period than in the double embryo transfer period: a retrospective analysis of women younger than 40 y | 27.3 | 0 | 2 |
| Effect of ultrasound-guided aspiration of hydrosalpingeal fluid during oocyte retrieval on the outcomes of in vitro fertilisation-embryo transfer: a randomised controlled trial (NCT01040351). | 27.3 | 0 | 2 |
| Impact of the mandatory age-based single-embryo transfer legislation in Turkey on outcome of in vitro fertilization: a multicentre study | 27.3 | 0 | 2 |
| Effect of pelvic inflammatory disease grades on in vitro fertilization-embryo transfer outcome | 27.3 | 0 | 2 |
| Pregnancy outcomes in a university hospital after legal requirement for single-embryo transfer | 27.3 | 0 | 2 |
| In vitro fertilization and embryo transfer in Pretoria | 27.3 | 0 | 2 |
| Selection of nonapoptotic spermatozoa as a new tool for enhancing assisted reproduction outcomes: an in vitro model | 27.3 | 0 | 2 |
| The use of time lapse photography in an in vitro fertilization programme for better selection for embryo transfer. | 27.3 | 0 | 2 |
| How do we decide how many embryos are safe for transfer? | 27.3 | 0 | 2 |
| No increase in autism-associated genetic events in children conceived by assisted reproduction | 27.3 | 0 | 2 |
| Luteal estrogen supplementation in stimulated cycles may improve the pregnancy rate in patients undergoing in vitro fertilization/intracytoplasmic sperm injection-embryo transfer | 27.3 | 0 | 2 |
| In vitro fertilization and embryo transfer in a Deaconess Institution. Experience from the first years | 27.3 | 0 | 2 |
| Three successful pregnancies with in vitro fertilization embryo transfer over an eight year time span despite elevated basal serum follicle stimulating hormone levels. Case report | 27.3 | 0 | 2 |
| Intramuscular progesterone (Gestone) versus vaginal progesterone suppository (Cyclogest) for luteal phase support in cycles of in vitro fertilization-embryo transfer: patient preference and drug efficacy | 27.3 | 0 | 2 |
| Fertility preservation in patients undergoing gonadotoxic therapy or gonadectomy: a committee opinion | 27.3 | 0 | 2 |
| Clinical results of Stanford University's in vitro fertilization and embryo transfer program | 27.3 | 0 | 2 |
| A controlled study between the use of gamete intrafallopian transfer (GIFT) and in vitro fertilization and embryo transfer in the management of idiopathic and male infertility | 27.3 | 0 | 2 |
| Phase III trial of 8% vaginal progesterone gel for luteal phase support in Japanese women undergoing in vitro fertilization and fresh embryo transfer cycles | 27.3 | 0 | 2 |
| Fertility outcomes in infertile women with complex hyperplasia or complex atypical hyperplasia who received progestin therapy and in vitro fertilization | 27.3 | 0 | 2 |
| In vitro maturation of human immature oocytes for fertility preservation and research material | 27.3 | 0 | 2 |
| Mesenteric vein thrombosis following impregnation via in vitro fertilization-embryo transfer | 27.3 | 0 | 2 |
| Not all twins are monozygotic after elective single embryo transfer: analysis of 32,600 elective single embryo transfer cycles as reported to the Society for Assisted Reproductive Technology | 27.3 | 0 | 2 |
| Medical egg freezing: the importance of a patient-centered approach to fertility preservation | 27.3 | 0 | 2 |
| Medical egg freezing and cancer patients' hopes: Fertility preservation at the intersection of life and death | 27.3 | 0 | 2 |
| Effect of Levothyroxine on Miscarriage Among Women With Normal Thyroid Function and Thyroid Autoimmunity Undergoing In Vitro Fertilization and Embryo Transfer: A Randomized Clinical Trial | 27.3 | 0 | 2 |
| Luteinizing hormone concentrations after gonadotropin-releasing hormone antagonist administration do not influence pregnancy rates in in vitro fertilization-embryo transfer | 27.3 | 0 | 2 |
| Reprotoxicity of intrauterine insemination and in vitro fertilization-embryo transfer disposables and products: a 4-year survey | 27.3 | 0 | 2 |
| Stimulation of endometrium embryo transfer can improve implantation and pregnancy rates for patients undergoing assisted reproductive technology for the first time with a high-grade blastocyst | 27.3 | 0 | 2 |
| In vitro fertilization and embryo transfer: medical technology + social values = legislative solutions. | 27.3 | 0 | 2 |
| Endometrial biopsy during hormone replacement cycle in donor oocyte recipients before in vitro fertilization-embryo transfer | 27.3 | 0 | 2 |
| Effect of preovulatory progesterone administration on the endometrial maturation and implantation rate after in vitro fertilization and embryo transfer | 27.3 | 0 | 2 |
| Weight loss improves reproductive outcomes in obese women undergoing fertility treatment: a randomized controlled trial | 27.3 | 0 | 2 |
| Findings on hysteroscopy in patients with in vitro fertilization by intra cytoplasmic single sperm injection and embryo transfer failures | 27.3 | 0 | 2 |
| Living Kinship Trouble: Danish Sperm Donors’ Narratives of Relatedness | 27.3 | 0 | 2 |
| Impact of a second insemination on the results of an in vitro fertilization-embryo transfer (IVF-ET) program | 27.3 | 0 | 2 |
| In vitro fertilization and embryo transfer: fertile areas for litigation | 27.3 | 0 | 2 |
| Optimization of Culture Conditions for Human In Vitro Fertilization and Embryo Transfer | 27.3 | 0 | 2 |
| Comparison of Pregnancy Stress Between In Vitro Fertilization/Embryo Transfer and Spontaneous Pregnancy in Women During Early Pregnancy | 27.3 | 0 | 2 |
| Association Between Pesticide Residue Intake From Consumption of Fruits and Vegetables and Pregnancy Outcomes Among Women Undergoing Infertility Treatment With Assisted Reproductive Technology | 27.3 | 0 | 2 |
| Effects of transcutaneous electrical acupoint stimulation on ovarian reserve of patients with diminished ovarian reserve in in vitro fertilization and embryo transfer cycles | 27.3 | 0 | 2 |
| “Will they be good enough parents?”: Ethical dilemmas, views, and decisions among assisted reproductive technology (ART) providers | 27.3 | 0 | 2 |
| The Importance of the Periconception Period: Immediate Effects in Cattle Breeding and in Assisted Reproduction Such as Artificial Insemination and Embryo Transfer | 27.3 | 0 | 2 |
| Provision of fertility services for women at increased risk of complications during fertility treatment or pregnancy: an Ethics Committee opinion | 27.3 | 0 | 2 |
| Financial "risk-sharing" or refund programs in assisted reproduction: an Ethics Committee opinion | 27.3 | 0 | 2 |
| Efficacy of dehydroepiandrosterone (DHEA) supplementation for in vitro fertilization and embryo transfer cycles: a systematic review and meta-analysis | 27.3 | 0 | 2 |
| The impact of the new Turkish regulation, imposing single embryo transfer after assisted reproduction technology, on neonatal intensive care unit utilization: a single center experience. | 27.3 | 0 | 2 |
| Suppression of Natural Killer Cell Activity and Interleukin‐2 Concentration of Serum Obtained from In Vitro Fertilization‐Embryo Transfer Patients | 27.3 | 0 | 2 |
| Influence of Antithyroid Antibodies in Euthyroid Women on In Vitro Fertilization‐Embryo Transfer Outcome | 27.3 | 0 | 2 |
| The determinant factors and the anxiety level of infertile couples during the treatment of in vitro fertilization and embryo transfer at Chulalongkorn Hospital | 27.3 | 0 | 2 |
| Donor Motivations, Associated Risks and Ethical Considerations of Oocyte Donation | 27.3 | 0 | 2 |
| Comparison between an exclusive in vitro-produced embryo transfer system and artificial insemination for genetic, technical, and financial herd performance | 27.3 | 0 | 2 |
| Intramural pregnancy associated with adenomyosis after in vitro fertilization and embryo transfer: a case report. | 27.3 | 0 | 2 |
| Assisted reproductive technology in the United States: 2001 results generated from the American Society for Reproductive Medicine/Society for Assisted Reproductive Technology registry | 27.3 | 0 | 2 |
| First llama (Lama glama) pregnancy obtained after in vitro fertilization and in vitro culture of gametes from live animals | 27.3 | 0 | 2 |
| Assisted reproductive technology in the United States: 2000 results generated from the American Society for Reproductive Medicine/Society for Assisted Reproductive Technology Registry | 27.3 | 0 | 2 |
| Assisted reproductive technology in the United States: 1999 results generated from the American Society for Reproductive Medicine/Society for Assisted Reproductive Technology Registry | 27.3 | 0 | 2 |
| Assisted reproductive technology in the United States: 1998 results generated from the American Society for Reproductive Medicine/Society for Assisted Reproductive Technology Registry | 27.3 | 0 | 2 |
| Effect of danazol on the pregnancy rate in patients with unsuccessful in vitro fertilization-embryo transfer | 27.3 | 0 | 2 |
| Embryo Transfer Following in Vitro and in Vivo Fertilization of Rabbit Ova | 27.3 | 0 | 2 |
| Effect of male body mass index on live-birth sex ratio of singletons after assisted reproduction technology | 27.3 | 0 | 2 |
| Assisted reproductive technology in reproductive medicine - possibilities and limitations | 27.3 | 0 | 2 |
| Reproductive Ethics in Commercial Surrogacy: Decision-Making in IVF Clinics in New Delhi, India | 27.3 | 0 | 2 |
| Impact of early cleaved zygote morphology on embryo development and in vitro fertilization-embryo transfer outcome: a prospective study | 27.3 | 0 | 2 |
| A prospective study using Hatha Yoga for stress reduction among women waiting for IVF treatment | 27.3 | 0 | 2 |
| Effect of premature serum progesterone rise on embryo transfer outcomes and the role of blastocyst culture and transfer in assisted reproductive technology cycles with premature progesterone rise | 27.3 | 0 | 2 |
| Serial Evaluation of Endometrial Blood Flow for Prediction of Pregnancy Outcomes in Patients Who Underwent Controlled Ovarian Hyperstimulation and In Vitro Fertilization and Embryo Transfer. | 27.3 | 0 | 2 |
| Costa Rica's absolute ban on in vitro fertilization deemed a human rights violation: implications for U.S. assisted reproductive technology policy and “personhood” initiatives | 27.3 | 0 | 2 |
| A comparative analysis of postpartum maternal mental health in women following spontaneous or ART conception | 27.3 | 0 | 2 |
| Heterotopic triplet pregnancy with an intrauterine, a tubal, and a cervical gestation following in vitro fertilization and embryo transfer | 27.3 | 0 | 2 |
| Influence of pituitary suppression with triphasic or monophasic oral contraceptives on the outcome of in vitro fertilization and embryo transfer | 27.3 | 0 | 2 |
| Melatonin concentration in follicular fluid is correlated with antral follicle count (AFC) and in vitro fertilization (IVF) outcomes in women undergoing assisted reproductive technology (ART) procedures. | 27.3 | 0 | 2 |
| Comparison of Follicle Isolation Methods for Mouse Ovarian Follicle Culture In Vitro | 27.3 | 0 | 2 |
| Patient and cycle characteristics predicting high pregnancy rates with single-embryo transfer: an analysis of the Society for Assisted Reproductive Technology outcomes between 2004 and 2013. | 27.3 | 0 | 2 |
| Mosaic embryo transfer after oocyte in vitro maturation in combination with non-invasive prenatal testing (NIPT)-first report of a euploid live birth | 27.3 | 0 | 2 |
| Initial maternal serum human chorionic gonadotropin levels in pregnancies achieved after assisted reproductive technology are higher after preimplantation genetic screening and after frozen embryo transfer: a retrospective cohort | 27.3 | 0 | 2 |
| There is no evidence that the time from egg retrieval to embryo transfer affects live birth rates in a freeze-all strategy | 27.3 | 0 | 2 |
| American Society for Reproductive Medicine Updates Consent Forms for Egg Donation | 27.3 | 0 | 2 |
| New look at endometrial echogenicity: objective computer-assisted measurements predict endometrial receptivity in in vitro fertilization-embryo transfer | 27.3 | 0 | 2 |
| Nondominant small follicles are a promising source of mature oocytes in modified natural cycle in vitro fertilization and embryo transfer | 27.3 | 0 | 2 |
| Comparison between follicular stimulation and luteal stimulation protocols with clomiphene and HMG in women with poor ovarian response | 27.3 | 0 | 2 |
| BRCA mutation carriers show normal ovarian response in in vitro fertilization cycles | 27.3 | 0 | 2 |
| Live birth following in vitro maturation of oocytes retrieved from extracorporeal ovarian tissue aspiration and embryo cryopreservation for 5 years | 27.3 | 0 | 2 |
| Live birth rates after IVF are lower with frozen donor eggs, study shows: | 27.3 | 0 | 2 |
| Differential expression of vascular endothelial growth factor angiogenic factors in different endometrial compartments in women who have an elevated progesterone level before oocyte retrieval, during in vitro fertilization-embryo transfer treatment | 27.3 | 0 | 2 |
| Uncommon but devastating event: total fertilisation failure following intracytoplasmic sperm injection | 27.3 | 0 | 2 |
| Ureteric Injury During Transvaginal Ultrasound Guided Oocyte Retrieval | 27.3 | 0 | 2 |
| Live birth in a 50-year-old woman following in vitro fertilization–embryo transfer with autologous oocytes: a rare case report | 27.3 | 0 | 2 |
| Maternal KIR haplotype influences live birth rate after double embryo transfer in IVF cycles in patients with recurrent miscarriages and implantation failure | 27.3 | 0 | 2 |
| Detection of endometrial and subendometrial vasculature on the day of embryo transfer and prediction of pregnancy during fresh in vitro fertilization cycles | 27.3 | 0 | 2 |
| Isolated polycystic morphology: Does it affect the IVF treatment outcomes? | 27.3 | 0 | 2 |
| Revised minimum standards for practices offering assisted reproductive technologies: a committee opinion | 27.3 | 0 | 2 |
| Tamoxifen co-administration during controlled ovarian hyperstimulation for in vitro fertilization in breast cancer patients increases the safety of fertility-preservation treatment strategies | 27.3 | 0 | 2 |
| Effect of soothing liver therapy on oocyte quality and growth differentiation factor-9 in patients undergoing in vitro fertilization and embryo transfer | 27.3 | 0 | 2 |
| Oral melatonin supplementation improves oocyte and embryo quality in women undergoing in vitro fertilization-embryo transfer | 27.3 | 0 | 2 |
| Pregnancy outcomes decline in recipients over age 44: an analysis of 27,959 fresh donor oocyte in vitro fertilization cycles from the Society for Assisted Reproductive Technology | 27.3 | 0 | 2 |
| Live birth after frozen-thawed oocytes maturedin vitroin a PCOS patient: a model for improving implantation rates in IVM cycles and objectively assessing the real potential of development of frozen oocytes maturedin vitro | 27.3 | 0 | 2 |
| The impact of legally restricted embryo transfer and reimbursement policy on cumulative delivery rate after treatment with assisted reproduction technology | 27.3 | 0 | 2 |
| Luteal-phase ovarian stimulation is feasible for producing competent oocytes in women undergoing in vitro fertilization/intracytoplasmic sperm injection treatment, with optimal pregnancy outcomes in frozen-thawed embryo transfer cycles | 27.3 | 0 | 2 |
| What is the quality of information on social oocyte cryopreservation provided by websites of Society for Assisted Reproductive Technology member fertility clinics? | 27.3 | 0 | 2 |
| Blastocyst biopsy with comprehensive chromosome screening and fresh embryo transfer significantly increases in vitro fertilization implantation and delivery rates: a randomized controlled trial | 27.3 | 0 | 2 |
| Insulin resistance does not affect early embryo development but lowers implantation rate in in vitro maturation–in vitro fertilization–embryo transfer cycle | 27.3 | 0 | 2 |
| Recommendations for gamete and embryo donation: a committee opinion | 27.3 | 0 | 2 |
| Effect of maternal age on the outcomes of in vitro fertilization and embryo transfer (IVF-ET). | 27.3 | 0 | 2 |
| Pregnancy outcome following in vitro fertilization-embryo transfer according to the percentage of metaphase II oocytes retrieved | 27.3 | 0 | 2 |
| Improved implantation and ongoing pregnancy rates after single-embryo transfer with an optimized protocol for in vitro oocyte maturation in women with polycystic ovaries and polycystic ovary syndrome | 27.3 | 0 | 2 |
| Comparative study on the pregnancy outcomes of in vitro fertilization-embryo transfer between long-acting gonadotropin-releasing hormone agonist combined with transvaginal ultrasound-guided cyst aspiration and long-acting gonadotropin-releasing horm | 27.3 | 0 | 2 |
| Asymmetrical dimethylarginine levels on the implantation success ofin vitrofertilization and embryo transfer | 27.3 | 0 | 2 |
| Antral follicle responsiveness to follicle-stimulating hormone administration assessed by the Follicular Output RaTe (FORT) may predict in vitro fertilization-embryo transfer outcome | 27.3 | 0 | 2 |
| Early pituitary desensitization and ovarian suppression with leuprolide acetate is associated with in vitro fertilization-embryo transfer success. | 27.3 | 0 | 2 |
| Prognostic value of beta-human chorionic gonadotropin is dependent on day of embryo transfer during in vitro fertilization | 27.3 | 0 | 2 |
| Successful pregnancy following in vitro fertilization embryo transfer in a 46-year-old woman with diminished oocyte reserve as evidenced by a high day 3 serum estradiol | 27.3 | 0 | 2 |
| Ureteral injury after transvaginal ultrasound-guided oocyte retrieval: a complication of in vitro fertilization-embryo transfer that may lurk undetected in women presenting with severe ovarian hyperstimulation syndrome | 27.3 | 0 | 2 |
| Impact of endometriosis on in vitro fertilization and embryo transfer cycles in young women: a stage-dependent interference | 27.3 | 0 | 2 |
| Effects on in vitro fertilization–embryo transfer outcomes of vascular endothelial growth factor receptor‐1, ‐2 and ‐3 in eutopic endometrial tissue of women with endometriosis | 27.3 | 0 | 2 |
| Initial experience with a risk-sharing in vitro fertilization-embryo transfer program with novel features | 27.3 | 0 | 2 |
| Cumulative live-birth delivery after IVF/ICSI since the progressive introduction of single-embryo transfer | 27.3 | 0 | 2 |
| Impact of embryo replacement depth on in vitro fertilization and embryo transfer outcomes. | 27.3 | 0 | 2 |
| Early and short follicular gonadotropin-releasing hormone antagonist supplementation improves the meiotic status and competence of retrieved oocytes in in vitro fertilization-embryo transfer cycles | 27.3 | 0 | 2 |
| Follicular growth and oocyte maturation in GnRH agonist and antagonist protocols for in vitro fertilisation and embryo transfer | 27.3 | 0 | 2 |
| Evaluation of compliance and range of fees among American Society for Reproductive Medicine-listed egg donor and surrogacy agencies | 27.3 | 0 | 2 |
| 2008 Guidelines for gamete and embryo donation: a Practice Committee report | 27.3 | 0 | 2 |
| Round spermatid nucleus injection (ROSNI). | 27.3 | 0 | 2 |
| Revised minimum standards for practices offering assisted reproductive technologies | 27.3 | 0 | 2 |
| Essential elements of informed consent for elective oocyte cryopreservation: a Practice Committee opinion | 27.3 | 0 | 2 |
| Improved pregnancy outcome for women with decreased ovarian oocyte reserve and advanced reproductive age by performing in vitro fertilization-embryo transfer | 27.3 | 0 | 2 |
| Field evaluation of juvenile in vitro embryo transfer (JIVET) in sheep | 27.3 | 0 | 2 |
| Amphiregulin is much more abundantly expressed than transforming growth factor-alpha and epidermal growth factor in human follicular fluid obtained from patients undergoing in vitro fertilization-embryo transfer | 27.3 | 0 | 2 |
| Effect of a woman's smoking status on oocyte, zygote, and day 3 pre-embryo quality in in vitro fertilization and embryo transfer program | 27.3 | 0 | 2 |
| Ultrashort gonadotropin-releasing hormone agonist combined with flexible multidose gonadotropin-releasing hormone antagonist for poor responders in in vitro fertilization/embryo transfer programs | 27.3 | 0 | 2 |
| Effect of 17alpha-hydroxyprogesterone caproate before embryo transfer on the outcome of in vitro fertilization and embryo transfer: a randomized trial | 27.3 | 0 | 2 |
| Anticardiolipin antibody levels in women undergoing first in vitro fertilization/embryo transfer. | 27.3 | 0 | 2 |
| Survivin gene expression in granulosa cells from infertile patients undergoing in vitro fertilization-embryo transfer | 27.3 | 0 | 2 |
| Does the timing of mock embryo transfer affect in vitro fertilization implantation and pregnancy rates? | 27.3 | 0 | 2 |
| The effect of retained embryos on pregnancy outcome in an in vitro fertilization and embryo transfer program | 27.3 | 0 | 2 |
| Prediction of ovarian reserve based on day-3 serum follicle stimulating hormone concentrations during the pituitary suppression cycle using a gonadotropin releasing hormone agonist in patients undergoing in vitro fertilization-embryo transfer | 27.3 | 0 | 2 |
| Outcome of in vitro fertilization-embryo transfer according to age in poor responders with elevated baseline serum follicle stimulation hormone using minimal or no gonadotropin stimulation. | 27.3 | 0 | 2 |
| Effect of treating sperm with low hypo-osmotic swelling test scores with chymotrypsin on pregnancy rates after conventional in vitro fertilization-embryo transfer | 27.3 | 0 | 2 |
| Follicular blood flow is a better predictor of the outcome of in vitro fertilization-embryo transfer than follicular fluid vascular endothelial growth factor and nitric oxide concentrations | 27.3 | 0 | 2 |
| Serum leptin concentrations in patients with severe ovarian hyperstimulation syndrome during in vitro fertilization-embryo transfer treatment | 27.3 | 0 | 2 |
| Ultrasound detection of pyometra at the time of embryo transfer after ovum retrieval for in vitro fertilization | 27.3 | 0 | 2 |
| Scavenger capacity of follicular fluid, decidua and culture medium with regard to assisted reproduction: an in vitro study using electron paramagnetic resonance spectroscopy | 27.3 | 0 | 2 |
| Assessment of leukemia inhibitory factor levels by uterine flushing at the time of egg retrieval does not adversely affect pregnancy rates with in vitro fertilization | 27.3 | 0 | 2 |
| Estimation of the contribution of non-assisted reproductive technology ovulation stimulation fertility treatments to US singleton and multiple births | 27.3 | 0 | 2 |
| Ultrasonographic assessment of endometrial receptivity at embryo transfer in an in vitro maturation of oocyte program | 27.3 | 0 | 2 |
| Utility of color Doppler indices of dominant follicular blood flow for prediction of clinical factors in in vitro fertilization-embryo transfer cycles | 27.3 | 0 | 2 |
| Prognosis following in vitro fertilization-embryo transfer (IVF-ET) in patients with elevated day 2 or 3 serum follicle stimulating hormone (FSH) is better in younger vs older patients | 27.3 | 0 | 2 |
| A prediction model for selecting patients undergoing in vitro fertilization for elective single embryo transfer | 27.3 | 0 | 2 |
| Assisted reproduction technique outcomes for fresh versus deferred cryopreserved day-2 embryo transfer: a retrospective matched cohort study | 27.3 | 0 | 2 |
| Recombinant human chorionic gonadotropin (rhCG) in assisted reproductive technology: results of a clinical trial comparing two doses of rhCG (Ovidrel) to urinary hCG (Profasi) for induction of final follicular maturation in in vitro fertilization-em | 27.3 | 0 | 2 |
| Massive retroperitoneal bleeding: a complication of transvaginal ultrasonography-guided oocyte retrieval for in vitro fertilization-embryo transfer | 27.3 | 0 | 2 |
| Zygote intrafallopian transfer in patients with tubal factor infertility after repeated failure of implantation with in vitro fertilization-embryo transfer | 27.3 | 0 | 2 |
| Pregnancy and delivery of healthy infants developed from vitrified oocytes in a stimulated in vitro fertilization-embryo transfer program | 27.3 | 0 | 2 |
| Gonadotropin stimulation following GnRH-a priming for poor responders in in vitro fertilization-embryo transfer programs | 27.3 | 0 | 2 |
| Pregnancies and deliveries after in vitro maturation culture followed by in vitro fertilization and embryo transfer without stimulation in women with polycystic ovary syndrome | 27.3 | 0 | 2 |
| CA-125 levels are related to the likelihood of pregnancy after in vitro fertilization and embryo transfer | 27.3 | 0 | 2 |
| Treatment outcome in women with a single ovary versus patients with two ovaries undergoing in vitro fertilization and embryo transfer (IVF/ET). | 27.3 | 0 | 2 |
| Moderate and severe endometriosis is associated with alterations in the cell cycle of granulosa cells in patients undergoing in vitro fertilization and embryo transfer | 27.3 | 0 | 2 |
| Prospective, randomized, controlled study of in vitro fertilization-embryo transfer with a single dose of a luteinizing hormone-releasing hormone (LH-RH) antagonist (cetrorelix) or a depot formula of an LH-RH agonist (triptorelin). | 27.3 | 0 | 2 |
| In vitro production of sexed embryos for gender preselection: high-speed sorting of X-chromosome-bearing sperm to produce pigs after embryo transfer | 27.3 | 0 | 2 |
| A comparison of the efficacy and tolerability of two recombinant human follicle-stimulating hormone preparations in patients undergoing in vitro fertilization-embryo transfer | 27.3 | 0 | 2 |
| uk’s Legalisation of Mitochondrial Donation in ivf Treatment: A Challenge to the International Community or a Promotion of Life-saving Medical Innovation to Be Followed by Others? | 27.3 | 0 | 2 |
| Clinical application of intracytoplasmic sperm injection using in vitro cultured testicular spermatozoa obtained the day before egg retrieval | 27.3 | 0 | 2 |
| Effect of a baseline ovarian cyst on the outcome of in vitro fertilization-embryo transfer | 27.3 | 0 | 2 |
| Interleukin-1β and interleukin-1α may affect the implantation rate of patients undergoing in vitro fertilization–embryo transfer | 27.3 | 0 | 2 |
| Multinucleation in normally fertilized embryos is associated with an accelerated ovulation induction response and lower implantation and pregnancy rates in in vitro fertilization-embryo transfer cycles | 27.3 | 0 | 2 |
| Success Rate with Repeated Cycles of In Vitro Fertilization–Embryo Transfer | 27.3 | 0 | 2 |
| Improved clinical outcomes for in vitro fertilization with delay of embryo transfer from 48 to 72 hours after oocyte retrieval: use of glucose- and phosphate-free media | 27.3 | 0 | 2 |
| Avoidance of oocyte retrieval on the weekend through the use of scheduled ovarian hyperstimulation for in vitro fertilization and embryo transfer | 27.3 | 0 | 2 |
| The outcome of in vitro fertilization and embryo transfer therapy in women with endometriosis failing to conceive after laparoscopic conservative surgery | 27.3 | 0 | 2 |
| Ethical issues of egg donation | 27.3 | 0 | 2 |
| Mouse in vitro fertilization, embryo development and viability, and human sperm motility in substances used for human sperm preparation for assisted reproduction | 27.3 | 0 | 2 |